Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2017 | May 03, 2017 | |
Document and Entity Information | ||
Entity Registrant Name | RIVERSOURCE LIFE INSURANCE CO | |
Entity Central Index Key | 727,892 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Document Type | 10-Q | |
Document Period End Date | Mar. 31, 2017 | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q1 | |
Amendment Flag | false | |
Entity Common Stock, Shares Outstanding | 100,000 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Available-for-Sale: | ||
Fixed maturities, at fair value (amortized cost: 2017, $21,169; 2016, $21,464) | $ 22,410 | $ 22,682 |
Common stocks, at fair value (cost: 2017 and 2016, $4) | 8 | 10 |
Mortgage loans, at amortized cost (less allowance for loan losses: 2017 and 2016, $19) | 2,862 | 2,874 |
Policy loans | 830 | 830 |
Other Investments | 992 | 998 |
Total investments | 27,102 | 27,394 |
Cash and cash equivalents | 326 | 323 |
Reinsurance recoverables | 2,642 | 2,623 |
Other receivables | 202 | 262 |
Accrued investment income | 226 | 237 |
Deferred acquisition costs | 2,608 | 2,611 |
Other assets | 3,747 | 4,305 |
Separate account assets | 78,053 | 76,298 |
Total assets | 114,906 | 114,053 |
Liabilities: | ||
Policyholder account balances, future policy benefits and claims | 29,067 | 29,514 |
Short-term borrowings | 200 | 200 |
Other liabilities | 3,866 | 4,253 |
Separate account liabilities | 78,053 | 76,298 |
Total liabilities | 111,186 | 110,265 |
Shareholder's equity: | ||
Common stock, $30 par value; 100,000 shares authorized, issued and outstanding | 3 | 3 |
Additional paid-in capital | 2,466 | 2,466 |
Retained earnings | 797 | 862 |
Accumulated other comprehensive income, net of tax | 454 | 457 |
Total shareholder's equity | 3,720 | 3,788 |
Total liabilities and shareholder's equity | $ 114,906 | $ 114,053 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Statement of Financial Position [Abstract] | ||
Fixed maturities, amortized cost | $ 21,169 | $ 21,464 |
Common stocks, cost | 4 | 4 |
Mortgage loans, allowance for loan losses | $ 19 | $ 19 |
Common stock, par value (in dollars per share) | $ 30 | $ 30 |
Common stock, shares authorized (in shares) | 100,000 | 100,000 |
Common stock, shares issued (in shares) | 100,000 | 100,000 |
Common stock, shares outstanding (in shares) | 100,000 | 100,000 |
CONSOLIDATED STATEMENTS OF INCO
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Revenues | ||
Premiums | $ 99 | $ 102 |
Net investment income | 271 | 290 |
Policy and contract charges | 483 | 469 |
Other revenues | 100 | 98 |
Net realized investment gains | 17 | 9 |
Total revenues | 970 | 968 |
Benefits and expenses | ||
Benefits, claims, losses and settlement expenses | 322 | 226 |
Interest credited to fixed accounts | 162 | 146 |
Amortization of deferred acquisition costs | 57 | 90 |
Other insurance and operating expenses | 177 | 177 |
Total benefits and expenses | 718 | 639 |
Pretax income | 252 | 329 |
Income tax provision | 17 | 54 |
Net Income | 235 | 275 |
Supplemental Disclosures: | ||
Total other-than-temporary impairment losses on securities | 0 | 0 |
Portion of loss recognized in other comprehensive income (before taxes) | 0 | 0 |
Net impairment losses recognized in net realized investment gains | $ 0 | $ 0 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Statement of Comprehensive Income [Abstract] | ||
Net Income | $ 235 | $ 275 |
Other comprehensive income (loss), net of tax: | ||
Net unrealized gains (losses) on securities | (3) | 176 |
Net unrealized gains on derivatives | 1 | 1 |
Other | (1) | 0 |
Total other comprehensive income (loss), net of tax | (3) | 177 |
Total comprehensive income | $ 232 | $ 452 |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY - USD ($) $ in Millions | Total | Common shares [Member] | Additional paid-in capital [Member] | Retained earnings [Member] | Accumulated other comprehensive income [Member] | |
Beginning balance at Dec. 31, 2015 | [1] | $ 4,039 | $ 3 | $ 2,465 | $ 1,176 | $ 395 |
Comprehensive income: | ||||||
Net Income | 275 | 275 | ||||
Other comprehensive income (loss), net of tax | 177 | 177 | ||||
Total comprehensive income | 452 | |||||
Cash dividends to Ameriprise Financial, Inc. | (400) | (400) | ||||
Ending balance at Mar. 31, 2016 | [1] | 4,091 | 3 | 2,465 | 1,051 | 572 |
Beginning balance at Dec. 31, 2016 | 3,788 | 3 | 2,466 | 862 | 457 | |
Comprehensive income: | ||||||
Net Income | 235 | 235 | ||||
Other comprehensive income (loss), net of tax | (3) | (3) | ||||
Total comprehensive income | 232 | |||||
Cash dividends to Ameriprise Financial, Inc. | (300) | (300) | ||||
Ending balance at Mar. 31, 2017 | $ 3,720 | $ 3 | $ 2,466 | $ 797 | $ 454 | |
[1] | Prior period retained earnings were restated in the fourth quarter of 2016. See Note 1 in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016. |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Statement of Cash Flows [Abstract] | ||
Net Income | $ 235 | $ 275 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation, amortization and accretion, net | 13 | 8 |
Deferred income tax expense (benefit) | (13) | 24 |
Contractholder and policyholder charges, non-cash | (90) | (86) |
Loss from equity method investments | 13 | 10 |
Net realized investment gains | (17) | (11) |
Other-than-temporary impairments and provision for loan losses recognized in net realized investment gains | 0 | 2 |
Change in operating assets and liabilities: | ||
Deferred acquisition costs | 3 | 27 |
Policyholder account balances, future policy benefits and claims, net | (352) | 730 |
Derivatives, net of collateral | 280 | (348) |
Reinsurance recoverables | (19) | (39) |
Other receivables | 36 | (51) |
Accrued investment income | 11 | 0 |
Other, net | (73) | 65 |
Net cash provided by operating activities | 27 | 606 |
Available-for-Sale securities: | ||
Proceeds from sales | 11 | 92 |
Maturities, sinking fund payments and calls | 707 | 434 |
Purchases | (409) | (534) |
Proceeds from sales, maturities and repayments of mortgage loans | 115 | 408 |
Funding of mortgage loans | (103) | (113) |
Proceeds from sales and collections of other investments | 57 | 21 |
Purchase of other investments | (45) | (36) |
Purchase of land, buildings, equipment and software | (1) | (2) |
Change in policy loans, net | 0 | (5) |
Other, net | 23 | (1) |
Net cash provided by investing activities | 355 | 264 |
Policyholder account balances: | ||
Deposits and other additions | 502 | 481 |
Net transfers (to) from separate accounts | (23) | 33 |
Surrenders and other benefits | (507) | (497) |
Proceeds from lines of credit with Ameriprise Financial, Inc. | 5 | 10 |
Payments on lines of credit with Ameriprise Financial, Inc. | (5) | (10) |
Cash received for purchased options with deferred premiums | 0 | 33 |
Cash paid for purchased options with deferred premiums | (51) | (76) |
Cash dividends to Ameriprise Financial, Inc. | (300) | (400) |
Net cash used in financing activities | (379) | (426) |
Net increase in cash and cash equivalents | 3 | 444 |
Cash and cash equivalents at beginning of period | 323 | 370 |
Cash and cash equivalents at end of period | 326 | 814 |
Supplemental Disclosures: | ||
Income taxes paid, net | 104 | 1 |
Non-cash investing activity: | ||
Partnership commitments not yet remitted | $ 9 | $ 10 |
Basis of Presentation
Basis of Presentation | 3 Months Ended |
Mar. 31, 2017 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | Basis of Presentation RiverSource Life Insurance Company is a stock life insurance company with one wholly owned stock life insurance company subsidiary, RiverSource Life Insurance Co. of New York (“RiverSource Life of NY”). RiverSource Life Insurance Company is a wholly owned subsidiary of Ameriprise Financial, Inc. (“Ameriprise Financial”). • RiverSource Life Insurance Company is domiciled in Minnesota and holds Certificates of Authority in American Samoa, the District of Columbia and all states except New York. RiverSource Life Insurance Company issues insurance and annuity products. • RiverSource Life of NY is domiciled and holds a Certificate of Authority in New York. RiverSource Life of NY issues insurance and annuity products. RiverSource Life Insurance Company also wholly owns RiverSource Tax Advantaged Investments, Inc. (“RTA”). RTA is a stock company domiciled in Delaware and is a limited partner in affordable housing partnership investments. The accompanying Consolidated Financial Statements include the accounts of RiverSource Life Insurance Company and companies in which it directly or indirectly has a controlling financial interest (collectively, the “Company”). All intercompany transactions and balances have been eliminated in consolidation. The interim financial information in this report has not been audited. In the opinion of management, all adjustments necessary for fair statement of the consolidated financial position and results of operations for the interim periods have been made. Except for the adjustment described below, all adjustments made were of a normal recurring nature. In the first quarter of 2017, the Company recorded a $20 million decrease to income tax provision related to an out-of-period correction for a reversal of a tax reserve. The impact to prior period financial statements was not material. The accompanying Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Results of operations reported for interim periods are not necessarily indicative of results for the entire year. These Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 , filed with the Securities and Exchange Commission on February 23, 2017 (“2016 10-K”). The Company evaluated events or transactions that may have occurred after the balance sheet date for potential recognition or disclosure through the date the financial statements were issued. No subsequent events or transactions were identified. |
Recent Accounting Pronouncement
Recent Accounting Pronouncements | 3 Months Ended |
Mar. 31, 2017 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
Recent Accounting Pronouncements | Recent Accounting Pronouncements Adoption of New Accounting Standards Statement of Cash Flows – Classification of Certain Cash Receipts and Cash Payments In August 2016, the Financial Accounting Standards Board (“FASB”) updated the accounting standards related to classification of certain cash receipts and cash payments on the statement of cash flows. The update includes amendments to address diversity in practice for the classification of eight specific cash flow activities. The specific amendments the Company evaluated include the classification of debt prepayment and extinguishment costs, contingent consideration payments, proceeds from insurance settlements and corporate owned life insurance settlements, distributions from equity method investees and the application of the predominance principle to separately identifiable cash flows. The standard is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted and all amendments must be adopted during the same period. The Company early adopted the standard for the interim period ended March 31, 2017 on a retrospective basis. The adoption of the standard did not have a material impact on the Company’s operating, investing or financing cash flows. Future Adoption of New Accounting Standards Receivables - Premium Amortization on Purchased Callable Debt Securities In March 2017, the FASB updated the accounting standards to shorten the amortization period for certain purchased callable debt securities held at a premium. Under current guidance, premiums are generally amortized over the contractual life of the security. The amendments require the premium to be amortized to the earliest call date. The update applies to securities with explicit, non-contingent call features that are callable at fixed prices and on preset dates. The standard is effective for interim and annual periods beginning after December 15, 2018, and should be applied on a modified retrospective basis through a cumulative-effect adjustment directly to retained earnings as of the beginning of the period of adoption. Early adoption is permitted. The update is not expected to have a material impact on the Company’s consolidated financial condition or results of operations. Income Taxes - Intra-Entity Transfers of Assets Other Than Inventory In October 2016, the FASB updated the accounting standards related to the recognition of income tax impacts on intra-entity transfers. The update requires entities to recognize the income tax consequences of intra-entity transfers, other than inventory, upon the transfer of the asset. The update requires the selling entity to recognize a current tax expense or benefit and the purchasing entity to recognize a deferred tax asset or liability when the transfer occurs. The standard is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial condition and results of operations. Financial Instruments – Measurement of Credit Losses In June 2016, the FASB updated the accounting standards related to accounting for credit losses on certain types of financial instruments. The update replaces the current incurred loss model for estimating credit losses with a new model that requires an entity to estimate the credit losses expected over the life of the asset. Generally, the initial estimate of the expected credit losses and subsequent changes in the estimate will be reported in current period earnings and recorded through an allowance for credit losses on the balance sheet. The current credit loss model for Available-for-Sale debt securities does not change; however, the credit loss calculation and subsequent recoveries are required to be recorded through an allowance. The standard is effective for interim and annual periods beginning after December 15, 2019. Early adoption will be permitted for interim and annual periods beginning after December 15, 2018. A modified retrospective cumulative adjustment to retained earnings should be recorded as of the first reporting period in which the guidance is effective for loans, receivables, and other financial instruments subject to the new expected credit loss model. Prospective adoption is required for establishing an allowance related to Available-for-Sale debt securities, certain beneficial interests, and financial assets purchased with a more-than-insignificant amount of credit deterioration since origination. The Company is currently evaluating the impact of the standard on its consolidated financial condition and results of operations. Leases – Recognition of Lease Assets and Liabilities on Balance Sheet In February 2016, the FASB updated the accounting standards for leases. The update was issued to increase transparency and comparability for the accounting of lease transactions. The standard will require most lease transactions for lessees to be recorded on the balance sheet as lease assets and lease liabilities and both quantitative and qualitative disclosures about leasing arrangements. The standard is effective for interim and annual periods beginning after December 15, 2018 with early adoption permitted. The update should be applied at the beginning of the earliest period presented using a modified retrospective approach. The Company is currently evaluating the impact of the standard on its consolidated financial condition and results of operations. Financial Instruments – Recognition and Measurement of Financial Assets and Financial Liabilities In January 2016, the FASB updated the accounting standards on the recognition and measurement of financial instruments. The update requires entities to carry marketable equity securities, excluding investments in securities that qualify for the equity method of accounting, at fair value with changes in fair value reflected in net income each reporting period. The update affects other aspects of accounting for equity instruments, as well as the accounting for financial liabilities utilizing the fair value option. The update eliminates the requirement to disclose the methods and assumptions used to estimate the fair value of financial assets or liabilities held at cost on the balance sheet and requires entities to use the exit price notion when measuring the fair value of financial instruments. The standard is effective for interim and annual periods beginning after December 15, 2017. Early adoption is permitted for certain provisions. Generally, the update should be applied using a modified retrospective approach by recording a cumulative-effect adjustment to equity at the beginning of the period of adoption. The update is not expected to have a material impact on the consolidated financial condition or results of operations. Revenue from Contracts with Customers In May 2014, the FASB updated the accounting standards for revenue from contracts with customers. The update provides a five step revenue recognition model for all revenue arising from contracts with customers and affects all entities that enter into contracts to provide goods or services to their customers (unless the contracts are in the scope of other standards). The standard also updates the accounting for certain costs associated with obtaining and fulfilling a customer contract and requires disclosure of quantitative and qualitative information that enables users of financial statements to understand the nature, amount, timing, and uncertainty of revenues and cash flows arising from contracts with customers. Subsequent related updates provide clarification on certain revenue recognition guidance in the new standard. The standard is effective for interim and annual periods beginning after December 15, 2017 and early adoption is permitted for interim and annual periods beginning after December 15, 2016. The standard may be applied retrospectively for all periods presented or retrospectively with a cumulative-effect adjustment at the date of adoption. The Company plans to adopt the revenue recognition guidance in the first quarter of 2018. The update does not apply to revenue associated with the manufacturing of insurance and annuity products or financial instruments as these revenues are in the scope of other standards. Therefore, the Company does not expect the update to have an impact on these revenues. The Company’s implementation efforts include the identification of revenue within the guidance and the review of the customer contracts to determine the Company’s performance obligation and the associated timing of each performance obligation. The Company is reviewing certain payments received to determine whether they should be presented as revenue or as a reduction of expense. The Company does not expect a material impact to the timing of revenue recognition; however, the Company’s implementation effort to assess the impact of the standard on its consolidated financial condition, results of operations, and disclosures is still in process. |
Variable Interest Entities Vari
Variable Interest Entities Variable Interest Entities | 3 Months Ended |
Mar. 31, 2017 | |
Variable Interest Entity, Nonconsolidated, Carrying Amount, Assets and Liabilities, Net [Abstract] | |
Variable Interest Entities [Text Block] | Variable Interest Entities The Company is a limited partner in affordable housing partnerships that qualify for government-sponsored low income housing tax credit programs and partnerships that invest in multi-family residential properties that were originally developed with an affordable housing component. The Company has determined it is not the primary beneficiary and therefore does not consolidate these partnerships. A majority of the limited partnerships are VIEs. The Company’s maximum exposure to loss as a result of its investment in the VIEs is limited to the carrying value. The carrying value is reflected in other investments and was $481 million and $482 million as of March 31, 2017 and December 31, 2016 , respectively. The Company had a $134 million and $135 million liability recorded as of March 31, 2017 and December 31, 2016 , respectively, related to original purchase commitments not yet remitted to the VIEs. The Company has not provided any additional support and is not contractually obligated to provide additional support to the VIEs beyond the above mentioned funding commitments. The Company invests in structured investments which are considered VIEs for which it is not the sponsor. These structured investments typically invest in fixed income instruments and are managed by third parties and include asset backed securities, commercial mortgage backed securities and residential mortgage backed securities. The Company classifies these investments as Available-for-Sale securities. The Company has determined that it is not the primary beneficiary of these structures due to the size of the Company’s investment in the entities and position in the capital structure of these entities. The Company’s maximum exposure to loss as a result of its investment in these structured investments is limited to its carrying value. The carrying value is included in Available-for-Sale fixed maturities on the Consolidated Balance Sheets. The Company has no obligation to provide financial or other support to the structured investments beyond its investment nor has the Company provided any support to the structured investments. See Note 4 for additional information on these structured investments. |
Investments
Investments | 3 Months Ended |
Mar. 31, 2017 | |
Investments, Debt and Equity Securities [Abstract] | |
Investments [Text Block] | Investments Available-for-Sale securities distributed by type were as follows: Description of Securities March 31, 2017 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Noncredit OTTI (1) (in millions) Fixed maturities: Corporate debt securities $ 12,941 $ 1,059 $ (38 ) $ 13,962 $ — Residential mortgage backed securities 3,320 66 (43 ) 3,343 (2 ) Commercial mortgage backed securities 2,732 55 (36 ) 2,751 — State and municipal obligations 1,102 164 (18 ) 1,248 — Asset backed securities 822 25 (8 ) 839 — Foreign government bonds and obligations 249 20 (5 ) 264 — U.S. government and agencies obligations 3 — — 3 — Total fixed maturities 21,169 1,389 (148 ) 22,410 (2 ) Common stocks 4 4 — 8 3 Total $ 21,173 $ 1,393 $ (148 ) $ 22,418 $ 1 Description of Securities December 31, 2016 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Noncredit OTTI (1) (in millions) Fixed maturities: Corporate debt securities $ 13,105 $ 1,060 $ (53 ) $ 14,112 $ — Residential mortgage backed securities 3,386 72 (43 ) 3,415 (4 ) Commercial mortgage backed securities 2,837 58 (38 ) 2,857 — State and municipal obligations 1,092 161 (24 ) 1,229 — Asset backed securities 790 26 (11 ) 805 — Foreign government bonds and obligations 251 17 (7 ) 261 — U.S. government and agencies obligations 3 — — 3 — Total fixed maturities 21,464 1,394 (176 ) 22,682 (4 ) Common stocks 4 6 — 10 3 Total $ 21,468 $ 1,400 $ (176 ) $ 22,692 $ (1 ) (1) Represents the amount of other-than-temporary impairment (“OTTI”) losses in accumulated other comprehensive income (“AOCI”). Amount includes unrealized gains and losses on impaired securities subsequent to the initial impairment measurement date. These amounts are included in gross unrealized gains and losses as of the end of the period. As of March 31, 2017 and December 31, 2016 , investment securities with a fair value of $1.4 billion and $1.5 billion , respectively, were pledged to meet contractual obligations under derivative contracts and short-term borrowings, of which $523 million and $428 million , respectively, may be sold, pledged or rehypothecated by the counterparty. As of both March 31, 2017 and December 31, 2016 , fixed maturity securities comprised approximately 83% of the Company’s total investments. Rating agency designations are based on the availability of ratings from Nationally Recognized Statistical Rating Organizations (“NRSROs”), including Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings Ltd. (“Fitch”). The Company uses the median of available ratings from Moody’s, S&P and Fitch, or if fewer than three ratings are available, the lower rating is used. When ratings from Moody’s, S&P and Fitch are unavailable, the Company may utilize ratings from other NRSROs or rate the securities internally. As of March 31, 2017 and December 31, 2016 , approximately $971 million and $944 million , respectively, of securities were internally rated by Columbia Management Investment Advisers, LLC, an affiliate of the Company, using criteria similar to those used by NRSROs. A summary of fixed maturity securities by rating was as follows: Ratings March 31, 2017 December 31, 2016 Amortized Cost Fair Value Percent of Total Fair Value Amortized Cost Fair Value Percent of Total Fair Value (in millions, except percentages) AAA $ 5,573 $ 5,619 25 % $ 5,671 $ 5,728 25 % AA 1,050 1,220 6 1,013 1,177 5 A 3,636 4,040 18 3,767 4,167 19 BBB 9,522 10,128 45 9,584 10,190 45 Below investment grade 1,388 1,403 6 1,429 1,420 6 Total fixed maturities $ 21,169 $ 22,410 100 % $ 21,464 $ 22,682 100 % As of March 31, 2017 and December 31, 2016 , approximately 39% and 40% , respectively, of the securities rated AAA were GNMA, FNMA and FHLMC mortgage backed securities. No holdings of any other issuer were greater than 10% of total equity. The following tables provide information about Available-for-Sale securities with gross unrealized losses and the length of time that individual securities have been in a continuous unrealized loss position: Description of Securities March 31, 2017 Less than 12 months 12 months or more Total Number Fair Value Unrealized Losses Number Fair Value Unrealized Losses Number Fair Value Unrealized Losses (in millions, except number of securities) Corporate debt securities 102 $ 1,331 $ (21 ) 22 $ 193 $ (17 ) 124 $ 1,524 $ (38 ) Residential mortgage backed securities 65 1,382 (28 ) 54 302 (15 ) 119 1,684 (43 ) Commercial mortgage backed securities 78 1,288 (36 ) 2 13 — 80 1,301 (36 ) State and municipal obligations 18 71 (3 ) 2 111 (15 ) 20 182 (18 ) Asset backed securities 15 150 (5 ) 14 139 (3 ) 29 289 (8 ) Foreign government bonds and obligations 4 10 — 14 21 (5 ) 18 31 (5 ) Total 282 $ 4,232 $ (93 ) 108 $ 779 $ (55 ) 390 $ 5,011 $ (148 ) Description of Securities December 31, 2016 Less than 12 months 12 months or more Total Number Fair Value Unrealized Losses Number Fair Value Unrealized Losses Number Fair Value Unrealized Losses (in millions, except number of securities) Corporate debt securities 114 $ 1,502 $ (26 ) 33 $ 319 $ (27 ) 147 $ 1,821 $ (53 ) Residential mortgage backed securities 56 1,282 (25 ) 56 324 (18 ) 112 1,606 (43 ) Commercial mortgage backed securities 80 1,378 (37 ) 1 11 (1 ) 81 1,389 (38 ) State and municipal obligations 18 66 (3 ) 2 105 (21 ) 20 171 (24 ) Asset backed securities 23 231 (6 ) 12 114 (5 ) 35 345 (11 ) Foreign government bonds and obligations 7 30 (1 ) 15 23 (6 ) 22 53 (7 ) Total 298 $ 4,489 $ (98 ) 119 $ 896 $ (78 ) 417 $ 5,385 $ (176 ) As part of the Company’s ongoing monitoring process, management determined that the change in gross unrealized losses on its Available-for-Sale securities is attributable to a slight decline in interest rates on the long end of the interest rate curve and a modest tightening of credit spreads. The following table presents a rollforward of the cumulative amounts recognized in the Consolidated Statements of Income for other-than-temporary impairments related to credit losses on Available-for-Sale securities for which a portion of the securities’ total other-than-temporary impairments was recognized in other comprehensive income (loss) (“OCI”): Three Months Ended March 31, 2017 2016 (in millions) Beginning balance $ 21 $ 33 Credit losses for which an other-than-temporary impairment was previously recognized — — Ending balance $ 21 $ 33 Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in net realized investment gains were as follows: Three Months Ended March 31, 2017 2016 (in millions) Gross realized investment gains $ 17 $ 3 Gross realized investment losses — (3 ) Total $ 17 $ — See Note 13 for a rollforward of net unrealized investment gains (losses) included in AOCI. Available-for-Sale securities by contractual maturity as of March 31, 2017 were as follows: Amortized Cost Fair Value (in millions) Due within one year $ 1,035 $ 1,052 Due after one year through five years 5,364 5,659 Due after five years through 10 years 4,157 4,276 Due after 10 years 3,739 4,490 14,295 15,477 Residential mortgage backed securities 3,320 3,343 Commercial mortgage backed securities 2,732 2,751 Asset backed securities 822 839 Common stocks 4 8 Total $ 21,173 $ 22,418 Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Residential mortgage backed securities, commercial mortgage backed securities and asset backed securities are not due at a single maturity date. As such, these securities, as well as common stocks, were not included in the maturities distribution. The following is a summary of net investment income: Three Months Ended March 31, 2017 2016 (in millions) Fixed maturities $ 242 $ 251 Mortgage loans 35 40 Other investments — 6 277 297 Less: investment expenses 6 7 Total $ 271 $ 290 |
Financing Receivables
Financing Receivables | 3 Months Ended |
Mar. 31, 2017 | |
Receivables [Abstract] | |
Financing Receivables [Text Block] | Financing Receivables The Company’s financing receivables include commercial and residential mortgage loans, syndicated loans and policy loans. Syndicated loans are reflected in other investments. Allowance for Loan Losses Policy loans do not exceed the cash surrender value of the policy at origination. As there is minimal risk of loss related to policy loans, the Company does not record an allowance for loan losses for policy loans. The Company does not currently have an allowance for loan losses for residential mortgage loans. The following table presents a rollforward of the allowance for loan losses for the three months ended and the ending balance of the allowance for loan losses by impairment method: March 31, 2017 2016 (in millions) Beginning balance $ 25 $ 25 Provisions — 1 Ending balance $ 25 $ 26 Individually evaluated for impairment $ 2 $ 4 Collectively evaluated for impairment 23 22 The recorded investment in financing receivables by impairment method was as follows: March 31, December 31, 2016 (in millions) Individually evaluated for impairment $ 18 $ 10 Collectively evaluated for impairment 3,252 3,275 Total $ 3,270 $ 3,285 As of March 31, 2017 and December 31, 2016 , the Company’s recorded investment in financing receivables individually evaluated for impairment for which there was no related allowance for loan losses was $12 million and $5 million , respectively. During the three months ended March 31, 2017 and 2016 , the Company purchased $54 million and $13 million , respectively, of syndicated loans. On March 30, 2016, the Company sold $250 million (amortized cost, net of unamortized discount) of its residential mortgage loans to an unaffiliated third party. The Company received cash proceeds of $260 million and recognized a gain of $10 million . Credit Quality Information Nonperforming loans, which are generally loans 90 days or more past due, were $2 million as of both March 31, 2017 and December 31, 2016 . All other loans were considered to be performing. Commercial Mortgage Loans The Company reviews the credit worthiness of the borrower and the performance of the underlying properties in order to determine the risk of loss on commercial mortgage loans. Based on this review, the commercial mortgage loans are assigned an internal risk rating, which management updates as necessary. Commercial mortgage loans which management has assigned its highest risk rating were 1% and nil of total commercial mortgage loans as of March 31, 2017 and December 31, 2016 , respectively. Loans with the highest risk rating represent distressed loans which the Company has identified as impaired or expects to become delinquent or enter into foreclosure within the next six months. In addition, the Company reviews the concentrations of credit risk by region and property type. Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows: Loans Percentage March 31, 2017 December 31, 2016 March 31, 2017 December 31, 2016 (in millions) South Atlantic $ 760 $ 753 29 % 29 % Pacific 714 722 28 28 Mountain 235 234 9 9 West North Central 213 212 8 8 Middle Atlantic 188 191 7 7 East North Central 200 195 8 8 West South Central 124 122 5 5 New England 82 84 3 3 East South Central 79 80 3 3 2,595 2,593 100 % 100 % Less: allowance for loan losses 19 19 Total $ 2,576 $ 2,574 Concentrations of credit risk of commercial mortgage loans by property type were as follows: Loans Percentage March 31, 2017 December 31, 2016 March 31, 2017 December 31, 2016 (in millions) Retail $ 897 $ 916 34 % 35 % Office 458 473 18 18 Apartments 511 483 20 19 Industrial 436 430 17 17 Mixed use 44 42 2 2 Hotel 41 41 1 1 Other 208 208 8 8 2,595 2,593 100 % 100 % Less: allowance for loan losses 19 19 Total $ 2,576 $ 2,574 Residential Mortgage Loans The recorded investment in residential mortgage loans as of March 31, 2017 and December 31, 2016 was $285 million and $300 million , respectively. The Company considers the credit worthiness of borrowers (FICO score), collateral characteristics such as loan-to-value (“LTV”) and geographic concentration to determine when an amount for an allowance for loan losses for residential mortgage loans is appropriate. At a minimum, management updates FICO scores and LTV ratios semiannually. As of March 31, 2017 and December 31, 2016 , no allowance for loan losses was recorded. As of both March 31, 2017 and December 31, 2016 , approximately 2% of residential mortgage loans had FICO scores below 640 . As of both March 31, 2017 and December 31, 2016 , none of the Company’s residential mortgage loans had LTV ratios greater than 90% . The Company’s most significant geographic concentrations for residential mortgage loans are in California representing 53% and 52% of the portfolio as of March 31, 2017 and December 31, 2016 , respectively. Colorado and Washington represent 17% and 13% , respectively, of the portfolio as of March 31, 2017 and 18% and 13% , respectively, as of December 31, 2016 . No other state represents more than 10% of the total residential mortgage loan portfolio. Syndicated Loans The recorded investment in syndicated loans as of March 31, 2017 and December 31, 2016 was $390 million and $392 million , respectively. The Company’s syndicated loan portfolio is diversified across industries and issuers. The primary credit indicator for syndicated loans is whether the loans are performing in accordance with the contractual terms of the syndication. Total nonperforming syndicated loans as of both March 31, 2017 and December 31, 2016 were $1 million . Troubled Debt Restructurings The recorded investment in restructured loans was not material as of March 31, 2017 and December 31, 2016 . The troubled debt restructurings did not have a material impact to the Company’s allowance for loan losses or income recognized for the three months ended March 31, 2017 and 2016 . There are no commitments to lend additional funds to borrowers whose loans have been restructured. |
Deferred Acquisition Costs and
Deferred Acquisition Costs and Deferred Sales Inducement Costs | 3 Months Ended |
Mar. 31, 2017 | |
Deferred Acquisition Costs and Deferred Sales Inducement Costs | |
Deferred Acquisition Costs and Deferred Sales Inducement Costs | Deferred Acquisition Costs and Deferred Sales Inducement Costs The balances of and changes in DAC were as follows: 2017 2016 (in millions) Balance at January 1 $ 2,611 $ 2,693 (1) Capitalization of acquisition costs 54 63 Amortization (57 ) (90 ) Impact of change in net unrealized securities gains — (47 ) Balance at March 31 $ 2,608 $ 2,619 (1) (1) DAC balances were restated for the correction of commission expense accrual for certain insurance and annuity products in the fourth quarter of 2016. See Note 1 in the 2016 10-K. The balances of and changes in DSIC, which is included in other assets, were as follows: 2017 2016 (in millions) Balance at January 1 $ 301 $ 334 Capitalization of sales inducement costs 2 1 Amortization (10 ) (12 ) Impact of change in net unrealized securities gains — (8 ) Balance at March 31 $ 293 $ 315 |
Policyholder Account Balances,
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities | 3 Months Ended |
Mar. 31, 2017 | |
Policyholder Account Balances, Future Policy Benefits and Claims & Separate Account Liabilities | |
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities | Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities Policyholder account balances, future policy benefits and claims consisted of the following: March 31, December 31, 2016 (in millions) Policyholder account balances Fixed annuities $ 10,400 $ 10,588 Variable annuity fixed sub-accounts 5,212 5,211 Variable universal life (“VUL”)/universal life (“UL”) insurance 3,011 3,007 Indexed universal life (“IUL”) insurance 1,127 1,054 Other life insurance 747 758 Total policyholder account balances 20,497 20,618 Future policy benefits Variable annuity guaranteed minimum withdrawal benefits (“GMWB”) 637 1,017 Variable annuity guaranteed minimum accumulation benefits (“GMAB”) (53 ) (1) (24 ) (1) Other annuity liabilities 71 66 Fixed annuities life contingent liabilities 1,488 1,497 Life, disability income and long term care insurance 5,610 5,556 VUL/UL and other life insurance additional liabilities 615 588 Total future policy benefits 8,368 8,700 Policy claims and other policyholders’ funds 202 196 Total policyholder account balances, future policy benefits and claims $ 29,067 $ 29,514 (1) Includes the fair value of GMAB embedded derivatives that was a net asset as of both March 31, 2017 and December 31, 2016 reported as a contra liability. Separate account liabilities consisted of the following: March 31, December 31, 2016 (in millions) Variable annuity $ 71,154 $ 69,606 VUL insurance 6,867 6,659 Other insurance 32 33 Total $ 78,053 $ 76,298 |
Variable Annuity and Insurance
Variable Annuity and Insurance Guarantees | 3 Months Ended |
Mar. 31, 2017 | |
Insurance [Abstract] | |
Variable Annuity and Insurance Guarantees | Variable Annuity and Insurance Guarantees The majority of the variable annuity contracts offered by the Company contain guaranteed minimum death benefit (“GMDB”) provisions. The Company also offers variable annuities with death benefit provisions that gross up the amount payable by a certain percentage of contract earnings, which are referred to as gain gross-up (“GGU”) benefits. In addition, the Company offers contracts with GMWB and GMAB provisions. The Company previously offered contracts containing guaranteed minimum income benefit (“GMIB”) provisions. Certain UL policies offered by the Company provide secondary guarantee benefits. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges. The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities: Variable Annuity Guarantees by Benefit Type (1) March 31, 2017 December 31, 2016 Total Contract Value Contract Value in Separate Accounts Net Amount at Risk Weighted Average Attained Age Total Contract Value Contract Value in Separate Accounts Net Amount at Risk Weighted Average Attained Age (in millions, except age) GMDB: Return of premium $ 57,540 $ 55,555 $ 50 66 $ 56,143 $ 54,145 $ 208 65 Five/six-year reset 8,919 6,198 16 66 8,878 6,170 22 66 One-year ratchet 6,474 6,102 33 68 6,426 6,050 110 68 Five-year ratchet 1,560 1,501 2 64 1,542 1,483 7 64 Other 997 973 71 71 965 942 86 71 Total — GMDB $ 75,490 $ 70,329 $ 172 66 $ 73,954 $ 68,790 $ 433 65 GGU death benefit $ 1,070 $ 1,019 $ 115 69 $ 1,047 $ 996 $ 108 68 GMIB $ 240 $ 222 $ 9 68 $ 245 $ 227 $ 13 68 GMWB: GMWB $ 2,615 $ 2,607 $ 2 70 $ 2,650 $ 2,642 $ 2 70 GMWB for life 40,729 40,594 221 66 39,436 39,282 495 66 Total — GMWB $ 43,344 $ 43,201 $ 223 66 $ 42,086 $ 41,924 $ 497 66 GMAB $ 3,385 $ 3,378 $ 4 59 $ 3,484 $ 3,476 $ 21 59 (1) Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table. The net amount at risk for GMDB, GGU and GMAB guarantees is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB and GMWB guarantees is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero. The present value is calculated using a discount rate that is consistent with assumptions embedded in the Company’s annuity pricing models. The following table provides information related to insurance guarantees for which the Company has established additional liabilities: March 31, 2017 December 31, 2016 Net Amount at Risk Weighted Average Attained Age Net Amount at Risk Weighted Average Attained Age (in millions, except age) UL secondary guarantees $ 6,407 64 $ 6,376 64 The net amount at risk for UL secondary guarantees is defined as the current guaranteed death benefit amount in excess of the current policyholder account balance. Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows: GMDB & GGU GMIB GMWB (1) GMAB (1) UL (in millions) Balance at January 1, 2016 $ 14 $ 8 $ 1,057 $ — $ 332 Incurred claims 4 — 649 31 22 Paid claims (4 ) — — — (6 ) Balance at March 31, 2016 $ 14 $ 8 $ 1,706 $ 31 $ 348 Balance at January 1, 2017 $ 16 $ 8 $ 1,017 $ (24 ) $ 434 Incurred claims 1 — (380 ) (29 ) 23 Paid claims (1 ) (1 ) — — (8 ) Balance at March 31, 2017 $ 16 $ 7 $ 637 $ (53 ) $ 449 (1) The incurred claims for GMWB and GMAB represent the change in the fair value of the liabilities (contra liabilities) less paid claims. The liabilities for guaranteed benefits are supported by general account assets. The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits: March 31, December 31, 2016 (in millions) Mutual funds: Equity $ 42,276 $ 40,622 Bond 23,220 23,142 Other 5,145 5,326 Total mutual funds $ 70,641 $ 69,090 |
Short-term Borrowings
Short-term Borrowings | 3 Months Ended |
Mar. 31, 2017 | |
Short-term Debt [Abstract] | |
Short-term Borrowings [Text Block] | Short-term Borrowings The Company enters into repurchase agreements in exchange for cash which it accounts for as secured borrowings and has pledged Available-for-Sale securities to collateralize its obligations under the repurchase agreements. As of both March 31, 2017 and December 31, 2016 , the Company has pledged $33 million of agency residential mortgage backed securities and $19 million of commercial mortgage backed securities. The amount of the Company’s liability including accrued interest as of both March 31, 2017 and December 31, 2016 was $50 million . The remaining maturity of outstanding repurchase agreements was less than four months as of March 31, 2017 and less than three months as of December 31, 2016 . The weighted average annualized interest rate on the repurchase agreements held as of March 31, 2017 and December 31, 2016 was 1.1% and 0.9% , respectively. RiverSource Life Insurance Company is a member of the Federal Home Loan Bank (“FHLB”) of Des Moines which provides access to collateralized borrowings. The Company has pledged Available-for-Sale securities consisting of commercial mortgage backed securities to collateralize its obligation under these borrowings. The fair value of the securities pledged is recorded in investments and was $769 million and $771 million as of March 31, 2017 and December 31, 2016 , respectively. The amount of the Company’s liability including accrued interest as of both March 31, 2017 and December 31, 2016 was $150 million . The remaining maturity of outstanding FHLB advances was less than three months as of March 31, 2017 and less than four months as of December 31, 2016 . The weighted average annualized interest rate on the FHLB advances held as of both March 31, 2017 and December 31, 2016 was 0.8% . |
Fair Values of Assets and Liabi
Fair Values of Assets and Liabilities | 3 Months Ended |
Mar. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair Values of Assets and Liabilities [Table Text Block] | Fair Values of Assets and Liabilities GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability is not exchanged subject to a forced liquidation or distressed sale. Valuation Hierarchy The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows: Level 1 Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date. Level 2 Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities. Level 3 Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The following tables present the balances of assets and liabilities measured at fair value on a recurring basis: March 31, 2017 Level 1 Level 2 Level 3 Total (in millions) Assets Available-for-Sale securities: Fixed maturities: Corporate debt securities $ — $ 12,777 $ 1,185 $ 13,962 Residential mortgage backed securities — 3,186 157 3,343 Commercial mortgage backed securities — 2,751 — 2,751 State and municipal obligations — 1,248 — 1,248 Asset backed securities — 790 49 839 Foreign government bonds and obligations — 264 — 264 U.S. government and agencies obligations 3 — — 3 Total Available-for-Sale securities: Fixed maturities 3 21,016 1,391 22,410 Common stocks 4 — 4 8 Cash equivalents — 316 — 316 Other assets: Interest rate derivative contracts — 1,107 — 1,107 Equity derivative contracts 40 1,580 — 1,620 Credit derivative contracts — 1 — 1 Foreign exchange derivative contracts — 59 — 59 Total other assets 40 2,747 — 2,787 Separate account assets measured at net asset value (“NAV”) 78,053 (1) Total assets at fair value $ 47 $ 24,079 $ 1,395 $ 103,574 Liabilities Policyholder account balances, future policy benefits and claims: EIA embedded derivatives $ — $ 4 $ — $ 4 IUL embedded derivatives — — 493 493 GMWB and GMAB embedded derivatives — — 188 188 (2) Total policyholder account balances, future policy benefits and claims — 4 681 685 (3) Other liabilities: Interest rate derivative contracts 1 461 — 462 Equity derivative contracts 9 2,197 — 2,206 Foreign exchange derivative contracts 1 37 — 38 Other derivative contracts — 4 — 4 Total other liabilities 11 2,699 — 2,710 Total liabilities at fair value $ 11 $ 2,703 $ 681 $ 3,395 December 31, 2016 Level 1 Level 2 Level 3 Total (in millions) Assets Available-for-Sale securities: Fixed maturities: Corporate debt securities $ — $ 12,955 $ 1,157 $ 14,112 Residential mortgage backed securities — 3,300 115 3,415 Commercial mortgage backed securities — 2,857 — 2,857 State and municipal obligations — 1,229 — 1,229 Asset backed securities — 792 13 805 Foreign government bonds and obligations — 261 — 261 U.S. government and agencies obligations 3 — — 3 Total Available-for-Sale securities: Fixed maturities 3 21,394 1,285 22,682 Common stocks 6 4 — 10 Cash equivalents — 302 — 302 Other assets: Interest rate derivative contracts — 1,735 — 1,735 Equity derivative contracts 42 1,481 — 1,523 Credit derivative contracts — 1 — 1 Foreign exchange derivative contracts — 80 — 80 Other derivative contracts 1 6 — 7 Total other assets 43 3,303 — 3,346 Separate account assets measured at NAV 76,298 (1) Total assets at fair value $ 52 $ 25,003 $ 1,285 $ 102,638 Liabilities Policyholder account balances, future policy benefits and claims: EIA embedded derivatives $ — $ 5 $ — $ 5 IUL embedded derivatives — — 464 464 GMWB and GMAB embedded derivatives — — 614 614 (4) Total policyholder account balances, future policy benefits and claims — 5 1,078 1,083 (5) Other liabilities: Interest rate derivative contracts 1 964 — 965 Equity derivative contracts 2 1,986 — 1,988 Foreign exchange derivative contracts 2 45 — 47 Other derivative contracts — 1 — 1 Total other liabilities 5 2,996 — 3,001 Total liabilities at fair value $ 5 $ 3,001 $ 1,078 $ 4,084 (1) Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. (2) The fair value of the GMWB and GMAB embedded derivatives included $585 million of individual contracts in a liability position and $397 million of individual contracts in an asset position as of March 31, 2017 . (3) The Company’s adjustment for nonperformance risk resulted in a $435 million cumulative decrease to the embedded derivatives as of March 31, 2017 . (4) The fair value of the GMWB and GMAB embedded derivatives included $880 million of individual contracts in a liability position and $266 million of individual contracts in an asset position as of December 31, 2016 . (5) The Company’s adjustment for nonperformance risk resulted in a $498 million cumulative decrease to the embedded derivatives as of December 31, 2016 . The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis: Available-for-Sale Securities: Fixed Maturities Corporate Debt Securities Residential Mortgage Backed Securities Asset Backed Securities Common Stocks Total (in millions) Balance, January 1, 2017 $ 1,157 $ 115 $ 13 $ — $ 1,285 Purchases 50 67 49 — 166 Settlements (22 ) (2 ) (13 ) — (37 ) Transfers into Level 3 — — — 4 4 Transfers out of Level 3 — (23 ) — — (23 ) Balance, March 31, 2017 $ 1,185 $ 157 $ 49 $ 4 $ 1,395 Changes in unrealized gains (losses) relating to assets held at March 31, 2017 $ — $ — $ — $ — $ — Policyholder Account Balances, Future Policy Benefits and Claims IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Total (in millions) Balance, January 1, 2017 $ 464 $ 614 $ 1,078 Total (gains) losses included in: Net income 19 (1) (499 ) (2) (480 ) Issues 22 77 99 Settlements (12 ) (4 ) (16 ) Balance, March 31, 2017 $ 493 $ 188 $ 681 Changes in unrealized (gains) losses relating to liabilities held at March 31, 2017 $ 19 (1) $ (484 ) (2) $ (465 ) Available-for-Sale Securities: Fixed Maturities Corporate Debt Securities Residential Mortgage Backed Securities Commercial Mortgage Backed Securities Asset Backed Securities Total (in millions) Balance, January 1, 2016 $ 1,235 $ 21 $ 3 $ 133 $ 1,392 Total gains included in: Other comprehensive income 16 — — — 16 Purchases — — 9 — 9 Settlements (8 ) (2 ) (2 ) — (12 ) Balance, March 31, 2016 $ 1,243 $ 19 $ 10 $ 133 $ 1,405 Changes in unrealized gains (losses) relating to assets held at March 31, 2016 $ — $ — $ — $ — $ — Policyholder Account Balances, Future Policy Benefits and Claims IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Total (in millions) Balance, January 1, 2016 $ 364 $ 851 $ 1,215 Total (gains) losses included in: Net income (8 ) (1) 602 (2) 594 Issues 32 68 100 Settlements (6 ) (6 ) (12 ) Balance, March 31, 2016 $ 382 $ 1,515 $ 1,897 Changes in unrealized (gains) losses relating to liabilities held at March 31, 2016 $ (8 ) (1) $ 616 (2) $ 608 (1) Included in interest credited to fixed accounts in the Consolidated Statements of Income. (2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. The increase (decrease) to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $(45) million and $189 million , net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual for the three months ended March 31, 2017 and 2016 , respectively. Securities transferred from Level 3 primarily represent securities with fair values that are now obtained from a third-party pricing service with observable inputs. Securities transferred to Level 3 represent securities with fair values that are now based on a single non-binding broker quote. The Company recognizes transfers between levels of the fair value hierarchy as of the beginning of the quarter in which each transfer occurred. For assets and liabilities held at the end of the reporting periods that are measured at fair value on a recurring basis, there were no transfers between Level 1 and Level 2. The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities: March 31, 2017 Fair Value Valuation Technique Unobservable Input Range Weighted Average (in millions) Corporate debt securities (private placements) $ 1,182 Discounted cash flow Yield/spread to U.S. Treasuries 0.9 % - 2.5% 1.3 % IUL embedded derivatives $ 493 Discounted cash flow Nonperformance risk (1) 80 bps GMWB and GMAB embedded derivatives $ 188 Discounted cash flow Utilization of guaranteed withdrawals (2) 0.0 % - 75.6% Surrender rate 0.1 % - 66.4% Market volatility (3) 5.0 % - 20.0% Nonperformance risk (1) 80 bps December 31, 2016 Fair Value Valuation Technique Unobservable Input Range Weighted Average (in millions) Corporate debt securities (private placements) $ 1,154 Discounted cash flow Yield/spread to U.S. Treasuries 0.9 % - 2.5% 1.3 % IUL embedded derivatives $ 464 Discounted cash flow Nonperformance risk (1) 82 bps GMWB and GMAB embedded derivatives $ 614 Discounted cash flow Utilization of guaranteed withdrawals (2) 0.0 % - 75.6% Surrender rate 0.1 % - 66.4% Market volatility (3) 5.3 % - 21.2% Nonperformance risk (1) 82 bps (1) The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. (2) The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. (3) Market volatility is implied volatility of fund of funds and managed volatility funds. Level 3 measurements not included in the table above are obtained from non-binding broker quotes where unobservable inputs utilized in the fair value calculation are not reasonably available to the Company. Sensitivity of Fair Value Measurements to Changes in Unobservable Inputs Significant increases (decreases) in the yield/spread to U.S. Treasuries used in the fair value measurement of Level 3 corporate debt securities in isolation would result in a significantly lower (higher) fair value measurement. Significant increases (decreases) in nonperformance risk used in the fair value measurement of the IUL embedded derivatives in isolation would result in a significantly lower (higher) fair value measurement. Significant increases (decreases) in utilization and volatility used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would result in a significantly higher (lower) liability value. Significant increases (decreases) in nonperformance risk and surrender rate used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would result in a significantly lower (higher) liability value. Utilization of guaranteed withdrawals and surrender rates vary with the type of rider, the duration of the policy, the age of the contractholder, the distribution channel and whether the value of the guaranteed benefit exceeds the contract accumulation value. Determination of Fair Value The Company uses valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The Company’s market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company’s income approach uses valuation techniques to convert future projected cash flows to a single discounted present value amount. When applying either approach, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy. Assets Cash Equivalents Cash equivalents include highly liquid investments with original maturities of 90 days or less. The Company’s cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization. Available-for-Sale Securities When available, the fair value of securities is based on quoted prices in active markets. If quoted prices are not available, fair values are obtained from third-party pricing services, non-binding broker quotes, or other model-based valuation techniques. Level 1 securities primarily include U.S. Treasuries. Level 2 securities primarily include corporate bonds, residential mortgage backed securities, commercial mortgage backed securities, state and municipal obligations, asset backed securities and U.S. agency and foreign government securities. The fair value of these Level 2 securities is based on a market approach with prices obtained from third-party pricing services. Observable inputs used to value these securities can include, but are not limited to, reported trades, benchmark yields, issuer spreads and non-binding broker quotes. Level 3 securities primarily include certain corporate bonds, non-agency residential mortgage backed securities and asset backed securities. The fair value of corporate bonds, non-agency residential mortgage backed securities and certain asset backed securities classified as Level 3 is typically based on a single non-binding broker quote. The underlying inputs used for some of the non-binding broker quotes are not readily available to the Company. The Company’s privately placed corporate bonds are typically based on a single non-binding broker quote. In addition to the general pricing controls, the Company reviews the broker prices to ensure that the broker quotes are reasonable and, when available, compares prices of privately issued securities to public issues from the same issuer to ensure that the implicit illiquidity premium applied to the privately placed investment is reasonable considering investment characteristics, maturity, and average life of the investment. In consideration of the above, management is responsible for the fair values recorded on the financial statements. Prices received from third-party pricing services are subjected to exception reporting that identifies investments with significant daily price movements as well as no movements. The Company reviews the exception reporting and resolves the exceptions through reaffirmation of the price or recording an appropriate fair value estimate. The Company also performs subsequent transaction testing. The Company performs annual due diligence of third-party pricing services. The Company’s due diligence procedures include assessing the vendor’s valuation qualifications, control environment, analysis of asset-class specific valuation methodologies, and understanding of sources of market observable assumptions and unobservable assumptions, if any, employed in the valuation methodology. The Company also considers the results of its exception reporting controls and any resulting price challenges that arise. Separate Account Assets The fair value of assets held by separate accounts is determined by the NAV of the funds in which those separate accounts are invested. The NAV is used as a practical expedient for fair value and represents the exit price for the separate account. Separate account assets are excluded from classification in the fair value hierarchy. Other Assets Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active over-the-counter (“OTC”) markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. Other derivative contracts consist of the Company’s macro hedge program. See Note 12 for further information on the macro hedge program. The counterparties’ nonperformance risk associated with uncollateralized derivative assets was immaterial as of March 31, 2017 and December 31, 2016 . See Note 11 and Note 12 for further information on the credit risk of derivative instruments and related collateral. Liabilities Policyholder Account Balances, Future Policy Benefits and Claims The Company values the embedded derivatives attributable to the provisions of certain variable annuity riders using internal valuation models. These models calculate fair value by discounting expected cash flows from benefits plus margins for profit, risk and expenses less embedded derivative fees. The projected cash flows used by these models include observable capital market assumptions and incorporate significant unobservable inputs related to contractholder behavior assumptions, implied volatility, and margins for risk, profit and expenses that the Company believes an exit market participant would expect. The fair value also reflects a current estimate of the Company’s nonperformance risk specific to these embedded derivatives. Given the significant unobservable inputs to this valuation, these measurements are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims. The Company uses various Black-Scholes calculations to determine the fair value of the embedded derivatives associated with the provisions of its EIA and IUL products. Significant inputs to the EIA calculation include observable interest rates, volatilities and equity index levels and, therefore, are classified as Level 2. The fair value of the IUL embedded derivatives includes significant observable interest rates, volatilities and equity index levels and the significant unobservable estimate of the Company’s nonperformance risk. Given the significance of the nonperformance risk assumption to the fair value, the IUL embedded derivatives are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims. The Company’s Corporate Actuarial Department calculates the fair value of the embedded derivatives on a monthly basis. During this process, control checks are performed to validate the completeness of the data. Actuarial management approves various components of the valuation along with the final results. The change in the fair value of the embedded derivatives is reviewed monthly with senior management. The Level 3 inputs into the valuation are consistent with the pricing assumptions and updated as experience develops. Significant unobservable inputs that reflect policyholder behavior are reviewed quarterly along with other valuation assumptions. Other Liabilities Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The variation margin on futures contracts is also classified as Level 1. The fair value of derivatives that are traded in less active OTC markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. Other derivative contracts consist of the Company’s macro hedge program. See Note 12 for further information on the macro hedge program. The Company’s nonperformance risk associated with uncollateralized derivative liabilities was immaterial as of March 31, 2017 and December 31, 2016 . See Note 11 and Note 12 for further information on the credit risk of derivative instruments and related collateral. During the reporting periods, there were no material assets or liabilities measured at fair value on a nonrecurring basis. The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value: March 31, 2017 Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) Financial Assets Mortgage loans, net $ 2,862 $ — $ — $ 2,874 $ 2,874 Policy loans 830 — — 791 791 Other investments 400 — 357 46 403 Financial Liabilities Policyholder account balances, future policy benefits and claims $ 10,715 $ — $ — $ 11,247 $ 11,247 Short-term borrowings 200 — 200 — 200 Other liabilities 171 — — 164 164 Separate account liabilities measured at NAV 347 347 (1) December 31, 2016 Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) Financial Assets Mortgage loans, net $ 2,874 $ — $ — $ 2,865 $ 2,865 Policy loans 830 — — 807 807 Other investments 402 — 364 43 407 Financial Liabilities Policyholder account balances, future policy benefits and claims $ 10,906 $ — $ — $ 11,417 $ 11,417 Short-term borrowings 200 — 200 — 200 Other liabilities 177 — — 169 169 Separate account liabilities measured at NAV 341 341 (1) (1) Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. Mortgage Loans, Net The fair value of commercial mortgage loans, except those with significant credit deterioration, is determined by discounting contractual cash flows using discount rates that reflect current pricing for loans with similar remaining maturities, liquidity and characteristics including LTV ratio, occupancy rate, refinance risk, debt service coverage, location, and property condition. For commercial mortgage loans with significant credit deterioration, fair value is determined using the same adjustments as above with an additional adjustment for the Company’s estimate of the amount recoverable on the loan. The fair value of residential mortgage loans is determined by discounting estimated cash flows and incorporating adjustments for prepayment, administration expenses, loss severity and credit loss estimates, with discount rates based on the Company’s estimate of current market conditions. Given the significant unobservable inputs to the valuation of mortgage loans, these measurements are classified as Level 3. Policy Loans Policy loans represent loans made against the cash surrender value of the underlying life insurance or annuity product. These loans and the related interest are usually realized at death of the policyholder or contractholder or at surrender of the contract and are not transferable without the underlying insurance or annuity contract. The fair value of policy loans is determined by estimating expected cash flows discounted at rates based on the U.S. Treasury curve. Policy loans are classified as Level 3 as the discount rate used may be adjusted for the underlying performance of individual policies. Other Investments Other investments primarily consist of syndicated loans and an investment in FHLB. The fair value of syndicated loans is obtained from a third-party pricing service or non-binding broker quotes. Syndicated loans that are priced using a market approach with observable inputs are classified as Level 2 and syndicated loans priced using a single non-binding broker quote are classified as Level 3. The fair value of the investment in FHLB is approximated by the carrying value and classified as Level 3 due to restrictions on transfer and lack of liquidity in the primary market for this asset. Policyholder Account Balances, Future Policy Benefits and Claims The fair value of fixed annuities in deferral status is determined by discounting cash flows using a risk neutral discount rate with adjustments for profit margin, expense margin, early policy surrender behavior, a margin for adverse deviation from estimated early policy surrender behavior and the Company’s nonperformance risk specific to these liabilities. The fair value of non-life contingent fixed annuities in payout status, EIA host contracts and the fixed portion of a small number of variable annuity contracts classified as investment contracts is determined in a similar manner. Given the use of significant unobservable inputs to these valuations, the measurements are classified as Level 3. Short-term Borrowings The fair value of short-term borrowings is obtained from a third-party pricing service. A nonperformance adjustment is not included as collateral requirements for these borrowings minimize the nonperformance risk. The fair value of short-term borrowings is classified as Level 2. Other Liabilities Other liabilities consist of future funding commitments to affordable housing partnerships and other real estate partnerships. The fair value of these future funding commitments is determined by discounting cash flows. The fair value of these commitments includes an adjustment for the Company’s nonperformance risk and is classified as Level 3 due to the use of the significant unobservable input. Separate Account Liabilities Certain separate account liabilities are classified as investment contracts and are carried at an amount equal to the related separate account assets. The NAV of the related separate account assets is used as a practical expedient for fair value and represents the exit price for the separate account liabilities. Separate account liabilities are excluded from classification in the fair value hierarchy. |
Offsetting Assets and Liabiliti
Offsetting Assets and Liabilities | 3 Months Ended |
Mar. 31, 2017 | |
Offsetting [Abstract] | |
Offsetting Assets and Liabilities [Text Block] | Offsetting Assets and Liabilities Certain financial instruments and derivative instruments are eligible for offset in the Consolidated Balance Sheets. The Company’s derivative instruments and repurchase agreements are subject to master netting arrangements and collateral arrangements and qualify for offset. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company’s policy is to recognize amounts subject to master netting arrangements on a gross basis in the Consolidated Balance Sheets. The following tables present the gross and net information about the Company’s assets subject to master netting arrangements: March 31, 2017 Gross Amounts of Recognized Assets Gross Amounts Offset in the Consolidated Balance Sheets Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,752 $ — $ 2,752 $ (2,202 ) $ (343 ) $ (201 ) $ 6 OTC cleared (2) 21 — 21 (21 ) — — — Exchange-traded 14 — 14 (2 ) — — 12 Total derivatives $ 2,787 $ — $ 2,787 $ (2,225 ) $ (343 ) $ (201 ) $ 18 December 31, 2016 Gross Amounts of Recognized Assets Gross Amounts Offset in the Consolidated Balance Sheets Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,822 $ — $ 2,822 $ (2,161 ) $ (374 ) $ (235 ) $ 52 OTC cleared 510 — 510 (507 ) (3 ) — — Exchange-traded 14 — 14 (2 ) — — 12 Total derivatives $ 3,346 $ — $ 3,346 $ (2,670 ) $ (377 ) $ (235 ) $ 64 (1) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. (2) The decrease in OTC cleared derivatives from December 31, 2016 is a result of certain central clearing parties amending their rules resulting in variation margin payments being settlement payments, as opposed to collateral. The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements: March 31, 2017 Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Consolidated Balance Sheets Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,684 $ — $ 2,684 $ (2,202 ) $ (1 ) $ (460 ) $ 21 OTC cleared (2) 23 — 23 (21 ) — — 2 Exchange-traded 3 — 3 (2 ) — — 1 Total derivatives 2,710 — 2,710 (2,225 ) (1 ) (460 ) 24 Repurchase agreements 50 — 50 — — (50 ) — Total $ 2,760 $ — $ 2,760 $ (2,225 ) $ (1 ) $ (510 ) $ 24 December 31, 2016 Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Consolidated Balance Sheets Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,481 $ — $ 2,481 $ (2,161 ) $ — $ (312 ) $ 8 OTC cleared 515 — 515 (507 ) (8 ) — — Exchange-traded 5 — 5 (2 ) — — 3 Total derivatives 3,001 — 3,001 (2,670 ) (8 ) (312 ) 11 Repurchase agreements 50 — 50 — — (50 ) — Total $ 3,051 $ — $ 3,051 $ (2,670 ) $ (8 ) $ (362 ) $ 11 (1) Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. (2) The decrease in OTC cleared derivatives from December 31, 2016 is a result of certain central clearing parties amending their rules resulting in variation margin payments being settlement payments, as opposed to collateral. In the tables above, the amounts of assets or liabilities presented in the Consolidated Balance Sheets are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral. The actual collateral may be greater than amounts presented in the tables. When the fair value of collateral accepted by the Company is less than the amount due to the Company, there is a risk of loss if the counterparty fails to perform or provide additional collateral. To mitigate this risk, the Company monitors collateral values regularly and requires additional collateral when necessary. When the value of collateral pledged by the Company declines, it may be required to post additional collateral. Freestanding derivative instruments are reflected in other assets and other liabilities. Cash collateral pledged by the Company is reflected in other assets and cash collateral accepted by the Company is reflected in other liabilities. Repurchase agreements are reflected in short-term borrowings. See Note 12 for additional disclosures related to the Company’s derivative instruments and Note 9 for additional disclosures related to the Company’s repurchase agreements. |
Derivatives and Hedging Activit
Derivatives and Hedging Activities | 3 Months Ended |
Mar. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivatives and Hedging Activities [Text Block] | Derivatives and Hedging Activities Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company’s products and operations. The Company’s freestanding derivative instruments are all subject to master netting arrangements. The Company’s policy on the recognition of derivatives on the Consolidated Balance Sheets is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. See Note 11 for additional information regarding the estimated fair value of the Company’s freestanding derivatives after considering the effect of master netting arrangements and collateral. The Company uses derivatives as economic hedges and accounting hedges. The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives: March 31, 2017 December 31, 2016 Notional Gross Fair Value Notional Gross Fair Value Assets (1) Liabilities (2) Assets (1) Liabilities (2) (in millions) Derivatives not designated as hedging instruments Interest rate contracts $ 69,800 $ 1,107 $ 462 $ 71,019 $ 1,735 $ 965 Equity contracts 58,967 1,620 2,206 59,401 1,523 1,988 Credit contracts 1,148 1 — 1,039 1 — Foreign exchange contracts 4,520 59 38 4,494 80 47 Other contracts 3,436 — 4 1,258 7 1 Total non-designated hedges 137,871 2,787 2,710 137,211 3,346 3,001 Embedded derivatives GMWB and GMAB (3) N/A — 188 N/A — 614 IUL N/A — 493 N/A — 464 EIA N/A — 4 N/A — 5 Total embedded derivatives N/A — 685 N/A — 1,083 Total derivatives $ 137,871 $ 2,787 $ 3,395 $ 137,211 $ 3,346 $ 4,084 N/A Not applicable. (1) The fair value of freestanding derivative assets is included in Other assets on the Consolidated Balance Sheets. (2) The fair value of freestanding derivative liabilities is included in Other liabilities on the Consolidated Balance Sheets. The fair value of GMWB and GMAB, IUL, and EIA embedded derivatives is included in Policyholder account balances, future policy benefits and claims on the Consolidated Balance Sheets. (3) The fair value of the GMWB and GMAB embedded derivatives as of March 31, 2017 included $585 million of individual contracts in a liability position and $397 million of individual contracts in an asset position. The fair value of the GMWB and GMAB embedded derivatives as of December 31, 2016 included $880 million of individual contracts in a liability position and $266 million of individual contracts in an asset position. See Note 10 for additional information regarding the Company’s fair value measurement of derivative instruments. As of March 31, 2017 and December 31, 2016 , investment securities with a fair value of $229 million and $235 million , respectively, wer e received as collateral to meet contractual obligations under derivative contracts, of which $124 million and $118 million , respectively, may be sold, pledged or rehypothecated by the Company. As of March 31, 2017 and December 31, 2016 , the Company had sold, pledged, or rehypothecated $14 million and $19 million , respectively, of these securities. In addition, as of March 31, 2017 and December 31, 2016 , non-cash collateral accepted was held in separate custodial accounts and was not included in the Company’s Consolidated Balance Sheets. The following tables present a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income: Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses (in millions) Three Months Ended March 31, 2017 Interest rate contracts $ — $ (75 ) Equity contracts 19 (416 ) Credit contracts — (8 ) Foreign exchange contracts — (24 ) Other contracts — (22 ) GMWB and GMAB embedded derivatives — 426 IUL embedded derivatives (7 ) — Total gain (loss) $ 12 $ (119 ) Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses (in millions) Three Months Ended March 31, 2016 Interest rate contracts $ — $ 755 Equity contracts (3 ) (65 ) Credit contracts — (16 ) Foreign exchange contracts — (35 ) GMWB and GMAB embedded derivatives — (664 ) IUL embedded derivatives 14 — Total gain (loss) $ 11 $ (25 ) The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company. Certain annuity contracts contain GMWB or GMAB provisions, which guarantee the right to make limited partial withdrawals each contract year regardless of the volatility inherent in the underlying investments or guarantee a minimum accumulation value of consideration received at the beginning of the contract period, after a specified holding period, respectively. The GMAB and non-life contingent GMWB provisions are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. The Company economically hedges the exposure related to GMAB and non-life contingent GMWB provisions primarily using futures, options, interest rate swaptions, interest rate swaps, total return swaps and variance swaps. The deferred premium associated with certain of the above options is paid or received semi-annually over the life of the option contract or at maturity. The following is a summary of the payments the Company is scheduled to make and receive for these options as of March 31, 2017 : Premiums Payable Premiums Receivable (in millions) 2017 (1) $ 210 $ 68 2018 210 129 2019 255 171 2020 176 98 2021 167 107 2022-2026 580 182 Total $ 1,598 $ 755 (1) 2017 amounts represent the amounts payable and receivable for the period from April 1, 2017 to December 31, 2017 . Actual timing and payment amounts may differ due to future contract settlements, modifications or exercises of options prior to the full premium being paid or received. The Company has a macro hedge program to provide protection against the statutory tail scenario risk arising from variable annuity reserves on its statutory surplus and to cover some of the residual risks not covered by other hedging activities. As a means of economically hedging these risks, the Company uses futures, options, swaps and swaptions. Certain of the macro hedge derivatives used contain settlement provisions linked to both equity returns and interest rates; the remaining are either interest rate contracts or equity contracts. The Company’s macro hedge derivatives are included in Other contracts in the tables above. EIA and IUL products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to EIA and IUL products will positively or negatively impact earnings over the life of these products. The equity component of the EIA and IUL product obligations are considered embedded derivatives, which are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. As a means of economically hedging its obligations under the provisions of these products, the Company enters into index options and futures contracts. Cash Flow Hedges During the three months ended March 31, 2017 , the Company held no derivatives that were designated as cash flow hedges. As of March 31, 2017 , the Company expects to reclassify $4 million of deferred losses on derivative instruments from AOCI to earnings during the next 12 months that will be recorded in net investment income. These were originally losses on derivative instruments related to interest rate swaptions. During the three months ended March 31, 2017 and 2016 , no hedge relationships were discontinued due to forecasted transactions no longer being expected to occur according to the original hedge strategy. For the three months ended March 31, 2017 and 2016 , amounts recognized in earnings on derivative transactions that were ineffective were not material. See Note 13 for a summary of net unrealized gains included in AOCI related to previously designated cash flow hedges. Currently, the longest period of time over which the Company is hedging exposure to the variability in future cash flows is two years and relates to interest credited on forecasted fixed premium product sales. Credit Risk Credit risk associated with the Company’s derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting arrangements and collateral arrangements whenever practical. See Note 11 for additional information on the Company’s credit exposure related to derivative assets. Certain of the Company’s derivative contracts contain provisions that adjust the level of collateral the Company is required to post based on the Company’s financial strength rating (or based on the debt rating of the Company’s parent, Ameriprise Financial). Additionally, certain of the Company’s derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company does not maintain a specific financial strength rating or Ameriprise Financial’s debt does not maintain a specific credit rating (generally an investment grade rating). If these termination provisions were to be triggered, the Company’s counterparty could require immediate settlement of any net liability position. As of March 31, 2017 and December 31, 2016 , the aggregate fair value of derivative contracts in a net liability position containing such credit contingent provisions was $305 million and $206 million , respectively. The aggregate fair value of assets posted as collateral for such instruments as of March 31, 2017 and December 31, 2016 was $284 million and $198 million , respectively. If the credit contingent provisions of derivative contracts in a net liability position as of March 31, 2017 and December 31, 2016 were triggered, the aggregate fair value of additional assets that would be required to be posted as collateral or needed to settle the instruments immediately would have been $21 million and $8 million , respectively. |
Shareholder's Equity
Shareholder's Equity | 3 Months Ended |
Mar. 31, 2017 | |
Stockholders' Equity Note [Abstract] | |
Shareholder's Equity [Text Block] | Shareholder’s Equity The following tables provide the amounts related to each component of OCI: Three Months Ended March 31, 2017 Pretax Income Tax Benefit (Expense) Net of Tax (in millions) Net unrealized securities losses: Net unrealized securities gains arising during the period (1) $ 38 $ (13 ) $ 25 Reclassification of net securities gains included in net income (2) (17 ) 6 (11 ) Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables (26 ) 9 (17 ) Net unrealized securities losses (5 ) 2 (3 ) Net unrealized derivatives gains: Reclassification of net derivative losses included in net income (3) 2 (1 ) 1 Net unrealized derivatives gains 2 (1 ) 1 Other (1 ) — (1 ) Other comprehensive loss $ (4 ) $ 1 $ (3 ) Three Months Ended March 31, 2016 Pretax Income Tax Benefit (Expense) Net of Tax (in millions) Net unrealized securities gains: Net unrealized securities gains arising during the period (1) $ 469 $ (165 ) $ 304 Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables (197 ) 69 (128 ) Net unrealized securities gains 272 (96 ) 176 Net unrealized derivatives gains: Reclassification of net derivative losses included in net income (3) 1 — 1 Net unrealized derivatives gains 1 — 1 Other comprehensive income $ 273 $ (96 ) $ 177 (1) Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income during the period. (2) Reclassification amounts are recorded in net realized investment gains. (3) Reclassification amounts are recorded in net investment income. Other comprehensive income (loss) related to net unrealized securities gains (losses) includes three components: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit other-than-temporary impairment losses to credit losses; and (iii) other adjustments primarily consisting of changes in insurance and annuity asset and liability balances, such as DAC, DSIC, unearned revenue, benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates. The following tables present the changes in the balances of each component of AOCI, net of tax: Net Unrealized Securities Gains Net Unrealized Derivatives Gains Other Total (in millions) Balance, January 1, 2017 $ 461 $ (4 ) $ — $ 457 OCI before reclassifications 8 — (1 ) 7 Amounts reclassified from AOCI (11 ) 1 — (10 ) Total OCI (3 ) 1 (1 ) (3 ) Balance, March 31, 2017 $ 458 (1) $ (3 ) $ (1 ) $ 454 Net Unrealized Securities Gains Net Unrealized Derivatives Gains Total (in millions) Balance, January 1, 2016 $ 403 $ (8 ) $ 395 OCI before reclassifications 176 1 177 Amounts reclassified from AOCI — — — Total OCI 176 1 177 Balance, March 31, 2016 $ 579 (1) $ (7 ) $ 572 (1) Includes $1 million and $(2) million of noncredit related impairments on securities and net unrealized securities gains (losses) on previously impaired securities as of March 31, 2017 and March 31, 2016 , respectively. |
Income Taxes
Income Taxes | 3 Months Ended |
Mar. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes The Company’s effective tax rate was 6.7% and 16.4% for the three months ended March 31, 2017 and 2016 , respectively. The effective tax rates are lower than the statutory rate as a result of tax preferred items including the dividends received deduction and low income housing tax credits. The decrease in the effective tax rate for the three months ended March 31, 2017 compared to the prior year period is primarily due to a $20 million benefit for a reversal of a tax reserve related to prior years. Included in the Company’s deferred income tax assets are tax benefits related to state net operating losses of $8 million , net of federal benefit, which will expire beginning December 31, 2017. The Company is required to establish a valuation allowance for any portion of the deferred tax assets that management believes will not be realized. Significant judgment is required in determining if a valuation allowance should be established, and the amount of such allowance if required. Factors used in making this determination include estimates relating to the performance of the business. Consideration is given to, among other things in making this determination, (i) future taxable income exclusive of reversing temporary differences and carryforwards, (ii) future reversals of existing taxable temporary differences, (iii) taxable income in prior carryback years, and (iv) tax planning strategies. Based on analysis of the Company’s tax position, management believes it is more likely than not that the results of future operations and implementation of tax planning strategies will not allow the Company to realize certain state deferred tax assets and state net operating losses. The valuation allowance for state deferred tax assets and state net operating losses was $8 million as of both March 31, 2017 and December 31, 2016 . As of March 31, 2017 and December 31, 2016 , the Company had $67 million and $59 million , respectively, of gross unrecognized tax benefits. If recognized, approximately $6 million , net of federal tax benefits, of unrecognized tax benefits as of both March 31, 2017 and December 31, 2016 , would affect the effective tax rate. The Company does not expect the total amount of unrecognized tax benefits to significantly change in the next 12 months. The Company recognizes interest and penalties related to unrecognized tax benefits as a component of the income tax provision. The Company recognized a net increase of $1 million and a net decrease of $39 million in interest and penalties for the three months ended March 31, 2017 , and 2016 , respectively. As of March 31, 2017 and December 31, 2016 , the Company had a payable of $3 million and $2 million , respectively, related to accrued interest and penalties. The Company or one or more of its subsidiaries files income tax returns as part of its inclusion in the consolidated federal income tax returns of Ameriprise Financial in the U.S. federal jurisdiction and various state jurisdictions. The IRS has completed its examination of the 2006 through 2011 tax returns, and these years are effectively settled; however, the statutes of limitation, except for 2007, remain open for certain carryover adjustments. The IRS is currently auditing the Company’s U.S. income tax returns for 2012 through 2015. The Company’s or certain of its subsidiaries’ state income tax returns are currently under examination by various jurisdictions for years ranging from 2010 through 2014. |
Contingencies
Contingencies | 3 Months Ended |
Mar. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Guarantees and Contingencies | Contingencies The Company is required by law to be a member of the guaranty fund association in every state where it is licensed to do business. In the event of insolvency of one or more unaffiliated insurance companies, the Company could be adversely affected by the requirement to pay assessments to the guaranty fund associations. The Company projects its cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations (“NOLHGA”) and the amount of its premiums written relative to the industry-wide premium in each state. The Company accrues the estimated cost of future guaranty fund assessments when it is considered probable that an assessment will be imposed, the event obligating the Company to pay the assessment has occurred and the amount of the assessment can be reasonably estimated. The Company has a liability for estimated guaranty fund assessments and a related premium tax asset. As of both March 31, 2017 and December 31, 2016 , the estimated liability was $16 million and the related premium tax asset was $14 million . The expected period over which guaranty fund assessments will be made and the related tax credits recovered is not known. Insurance companies have been the subject of increasing regulatory, legislative and judicial scrutiny. Numerous state and federal regulatory agencies have commenced examinations and other inquiries of insurance companies regarding sales and marketing practices (including sales to older consumers and disclosure practices), claims handling, and unclaimed property and escheatment practices and procedures. The Company has cooperated and will continue to cooperate with the applicable regulators. The Company is involved in the normal course of business in a number of other legal and arbitration proceedings concerning matters arising in connection with the conduct of its business activities. The Company believes that it is not a party to, nor are any of its properties the subject of, any pending legal, arbitration or regulatory investigation, examination or proceeding that is likely to have a material adverse effect on its consolidated financial condition, results of operations or liquidity. Notwithstanding the foregoing, it is possible that the outcome of any current or future legal, arbitration or regulatory proceeding could have a material impact on results of operations in any particular reporting period as the proceedings are resolved. Uncertain economic conditions, heightened and sustained volatility in the financial markets and significant financial reform legislation may increase the likelihood that clients and other persons or regulators may present or threaten legal claims or that regulators increase the scope or frequency of examinations of the Company or the insurance industry generally. |
Investments (Tables)
Investments (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Investments, Debt and Equity Securities [Abstract] | |
Available-for-Sale Securities Disclosure [Table Text Block] | Available-for-Sale securities distributed by type were as follows: Description of Securities March 31, 2017 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Noncredit OTTI (1) (in millions) Fixed maturities: Corporate debt securities $ 12,941 $ 1,059 $ (38 ) $ 13,962 $ — Residential mortgage backed securities 3,320 66 (43 ) 3,343 (2 ) Commercial mortgage backed securities 2,732 55 (36 ) 2,751 — State and municipal obligations 1,102 164 (18 ) 1,248 — Asset backed securities 822 25 (8 ) 839 — Foreign government bonds and obligations 249 20 (5 ) 264 — U.S. government and agencies obligations 3 — — 3 — Total fixed maturities 21,169 1,389 (148 ) 22,410 (2 ) Common stocks 4 4 — 8 3 Total $ 21,173 $ 1,393 $ (148 ) $ 22,418 $ 1 Description of Securities December 31, 2016 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Noncredit OTTI (1) (in millions) Fixed maturities: Corporate debt securities $ 13,105 $ 1,060 $ (53 ) $ 14,112 $ — Residential mortgage backed securities 3,386 72 (43 ) 3,415 (4 ) Commercial mortgage backed securities 2,837 58 (38 ) 2,857 — State and municipal obligations 1,092 161 (24 ) 1,229 — Asset backed securities 790 26 (11 ) 805 — Foreign government bonds and obligations 251 17 (7 ) 261 — U.S. government and agencies obligations 3 — — 3 — Total fixed maturities 21,464 1,394 (176 ) 22,682 (4 ) Common stocks 4 6 — 10 3 Total $ 21,468 $ 1,400 $ (176 ) $ 22,692 $ (1 ) (1) Represents the amount of other-than-temporary impairment (“OTTI”) losses in accumulated other comprehensive income (“AOCI”). Amount includes unrealized gains and losses on impaired securities subsequent to the initial impairment measurement date. These amounts are included in gross unrealized gains and losses as of the end of the period. |
Fixed Maturity Securities by Rating Disclosure [Table Text Block] | A summary of fixed maturity securities by rating was as follows: Ratings March 31, 2017 December 31, 2016 Amortized Cost Fair Value Percent of Total Fair Value Amortized Cost Fair Value Percent of Total Fair Value (in millions, except percentages) AAA $ 5,573 $ 5,619 25 % $ 5,671 $ 5,728 25 % AA 1,050 1,220 6 1,013 1,177 5 A 3,636 4,040 18 3,767 4,167 19 BBB 9,522 10,128 45 9,584 10,190 45 Below investment grade 1,388 1,403 6 1,429 1,420 6 Total fixed maturities $ 21,169 $ 22,410 100 % $ 21,464 $ 22,682 100 % |
Available-for-Sale Securities Continuous Unrealized Loss Disclosure [Table Text Block] | The following tables provide information about Available-for-Sale securities with gross unrealized losses and the length of time that individual securities have been in a continuous unrealized loss position: Description of Securities March 31, 2017 Less than 12 months 12 months or more Total Number Fair Value Unrealized Losses Number Fair Value Unrealized Losses Number Fair Value Unrealized Losses (in millions, except number of securities) Corporate debt securities 102 $ 1,331 $ (21 ) 22 $ 193 $ (17 ) 124 $ 1,524 $ (38 ) Residential mortgage backed securities 65 1,382 (28 ) 54 302 (15 ) 119 1,684 (43 ) Commercial mortgage backed securities 78 1,288 (36 ) 2 13 — 80 1,301 (36 ) State and municipal obligations 18 71 (3 ) 2 111 (15 ) 20 182 (18 ) Asset backed securities 15 150 (5 ) 14 139 (3 ) 29 289 (8 ) Foreign government bonds and obligations 4 10 — 14 21 (5 ) 18 31 (5 ) Total 282 $ 4,232 $ (93 ) 108 $ 779 $ (55 ) 390 $ 5,011 $ (148 ) Description of Securities December 31, 2016 Less than 12 months 12 months or more Total Number Fair Value Unrealized Losses Number Fair Value Unrealized Losses Number Fair Value Unrealized Losses (in millions, except number of securities) Corporate debt securities 114 $ 1,502 $ (26 ) 33 $ 319 $ (27 ) 147 $ 1,821 $ (53 ) Residential mortgage backed securities 56 1,282 (25 ) 56 324 (18 ) 112 1,606 (43 ) Commercial mortgage backed securities 80 1,378 (37 ) 1 11 (1 ) 81 1,389 (38 ) State and municipal obligations 18 66 (3 ) 2 105 (21 ) 20 171 (24 ) Asset backed securities 23 231 (6 ) 12 114 (5 ) 35 345 (11 ) Foreign government bonds and obligations 7 30 (1 ) 15 23 (6 ) 22 53 (7 ) Total 298 $ 4,489 $ (98 ) 119 $ 896 $ (78 ) 417 $ 5,385 $ (176 ) |
Credit Losses on Available-for-Sale Securities Disclosure [Table Text Block] | The following table presents a rollforward of the cumulative amounts recognized in the Consolidated Statements of Income for other-than-temporary impairments related to credit losses on Available-for-Sale securities for which a portion of the securities’ total other-than-temporary impairments was recognized in other comprehensive income (loss) (“OCI”): Three Months Ended March 31, 2017 2016 (in millions) Beginning balance $ 21 $ 33 Credit losses for which an other-than-temporary impairment was previously recognized — — Ending balance $ 21 $ 33 |
Net Realized Gains and Losses on Available-for-Sale Securities Disclosure [Table Text Block] | Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in net realized investment gains were as follows: Three Months Ended March 31, 2017 2016 (in millions) Gross realized investment gains $ 17 $ 3 Gross realized investment losses — (3 ) Total $ 17 $ — |
Available-for-Sale Securities Contractual Maturity Disclosure [Table Text Block] | Available-for-Sale securities by contractual maturity as of March 31, 2017 were as follows: Amortized Cost Fair Value (in millions) Due within one year $ 1,035 $ 1,052 Due after one year through five years 5,364 5,659 Due after five years through 10 years 4,157 4,276 Due after 10 years 3,739 4,490 14,295 15,477 Residential mortgage backed securities 3,320 3,343 Commercial mortgage backed securities 2,732 2,751 Asset backed securities 822 839 Common stocks 4 8 Total $ 21,173 $ 22,418 |
Schedule of Net Investment Income [Table Text Block] | The following is a summary of net investment income: Three Months Ended March 31, 2017 2016 (in millions) Fixed maturities $ 242 $ 251 Mortgage loans 35 40 Other investments — 6 277 297 Less: investment expenses 6 7 Total $ 271 $ 290 |
Financing Receivables (Tables)
Financing Receivables (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Receivables [Abstract] | |
Rollforward of the Allowance for Loan Losses [Table Text Block] | The following table presents a rollforward of the allowance for loan losses for the three months ended and the ending balance of the allowance for loan losses by impairment method: March 31, 2017 2016 (in millions) Beginning balance $ 25 $ 25 Provisions — 1 Ending balance $ 25 $ 26 Individually evaluated for impairment $ 2 $ 4 Collectively evaluated for impairment 23 22 |
Schedule of Recorded Investment in Financing Receivables by Impairment Method [Table Text Block] | The recorded investment in financing receivables by impairment method was as follows: March 31, December 31, 2016 (in millions) Individually evaluated for impairment $ 18 $ 10 Collectively evaluated for impairment 3,252 3,275 Total $ 3,270 $ 3,285 |
Schedule of Commercial Mortgage Loans by Geographic Region [Table Text Block] | Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows: Loans Percentage March 31, 2017 December 31, 2016 March 31, 2017 December 31, 2016 (in millions) South Atlantic $ 760 $ 753 29 % 29 % Pacific 714 722 28 28 Mountain 235 234 9 9 West North Central 213 212 8 8 Middle Atlantic 188 191 7 7 East North Central 200 195 8 8 West South Central 124 122 5 5 New England 82 84 3 3 East South Central 79 80 3 3 2,595 2,593 100 % 100 % Less: allowance for loan losses 19 19 Total $ 2,576 $ 2,574 |
Schedule of Commercial Mortgage Loans by Property Type [Table Text Block] | Concentrations of credit risk of commercial mortgage loans by property type were as follows: Loans Percentage March 31, 2017 December 31, 2016 March 31, 2017 December 31, 2016 (in millions) Retail $ 897 $ 916 34 % 35 % Office 458 473 18 18 Apartments 511 483 20 19 Industrial 436 430 17 17 Mixed use 44 42 2 2 Hotel 41 41 1 1 Other 208 208 8 8 2,595 2,593 100 % 100 % Less: allowance for loan losses 19 19 Total $ 2,576 $ 2,574 |
Deferred Acquisition Costs an25
Deferred Acquisition Costs and Deferred Sales Inducement Costs (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Deferred Acquisition Costs and Deferred Sales Inducement Costs | |
Schedule of balances of and changes in DAC | The balances of and changes in DAC were as follows: 2017 2016 (in millions) Balance at January 1 $ 2,611 $ 2,693 (1) Capitalization of acquisition costs 54 63 Amortization (57 ) (90 ) Impact of change in net unrealized securities gains — (47 ) Balance at March 31 $ 2,608 $ 2,619 (1) (1) DAC balances were restated for the correction of commission expense accrual for certain insurance and annuity products in the fourth quarter of 2016. See Note 1 in the 2016 10-K. |
Schedule of balances of and changes in DSIC | The balances of and changes in DSIC, which is included in other assets, were as follows: 2017 2016 (in millions) Balance at January 1 $ 301 $ 334 Capitalization of sales inducement costs 2 1 Amortization (10 ) (12 ) Impact of change in net unrealized securities gains — (8 ) Balance at March 31 $ 293 $ 315 |
Policyholder Account Balances26
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Policyholder Account Balances, Future Policy Benefits and Claims & Separate Account Liabilities | |
Policyholder Account Balances, Future Policy Benefits and Claims Disclosure | Policyholder account balances, future policy benefits and claims consisted of the following: March 31, December 31, 2016 (in millions) Policyholder account balances Fixed annuities $ 10,400 $ 10,588 Variable annuity fixed sub-accounts 5,212 5,211 Variable universal life (“VUL”)/universal life (“UL”) insurance 3,011 3,007 Indexed universal life (“IUL”) insurance 1,127 1,054 Other life insurance 747 758 Total policyholder account balances 20,497 20,618 Future policy benefits Variable annuity guaranteed minimum withdrawal benefits (“GMWB”) 637 1,017 Variable annuity guaranteed minimum accumulation benefits (“GMAB”) (53 ) (1) (24 ) (1) Other annuity liabilities 71 66 Fixed annuities life contingent liabilities 1,488 1,497 Life, disability income and long term care insurance 5,610 5,556 VUL/UL and other life insurance additional liabilities 615 588 Total future policy benefits 8,368 8,700 Policy claims and other policyholders’ funds 202 196 Total policyholder account balances, future policy benefits and claims $ 29,067 $ 29,514 (1) Includes the fair value of GMAB embedded derivatives that was a net asset as of both March 31, 2017 and December 31, 2016 reported as a contra liability. |
Schedule of Separate Account Liabilities by Policy Type | Separate account liabilities consisted of the following: March 31, December 31, 2016 (in millions) Variable annuity $ 71,154 $ 69,606 VUL insurance 6,867 6,659 Other insurance 32 33 Total $ 78,053 $ 76,298 |
Variable Annuity and Insuranc27
Variable Annuity and Insurance Guarantees (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Insurance [Abstract] | |
Schedule of Variable Annuity Guarantees [Table Text Block] | The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities: Variable Annuity Guarantees by Benefit Type (1) March 31, 2017 December 31, 2016 Total Contract Value Contract Value in Separate Accounts Net Amount at Risk Weighted Average Attained Age Total Contract Value Contract Value in Separate Accounts Net Amount at Risk Weighted Average Attained Age (in millions, except age) GMDB: Return of premium $ 57,540 $ 55,555 $ 50 66 $ 56,143 $ 54,145 $ 208 65 Five/six-year reset 8,919 6,198 16 66 8,878 6,170 22 66 One-year ratchet 6,474 6,102 33 68 6,426 6,050 110 68 Five-year ratchet 1,560 1,501 2 64 1,542 1,483 7 64 Other 997 973 71 71 965 942 86 71 Total — GMDB $ 75,490 $ 70,329 $ 172 66 $ 73,954 $ 68,790 $ 433 65 GGU death benefit $ 1,070 $ 1,019 $ 115 69 $ 1,047 $ 996 $ 108 68 GMIB $ 240 $ 222 $ 9 68 $ 245 $ 227 $ 13 68 GMWB: GMWB $ 2,615 $ 2,607 $ 2 70 $ 2,650 $ 2,642 $ 2 70 GMWB for life 40,729 40,594 221 66 39,436 39,282 495 66 Total — GMWB $ 43,344 $ 43,201 $ 223 66 $ 42,086 $ 41,924 $ 497 66 GMAB $ 3,385 $ 3,378 $ 4 59 $ 3,484 $ 3,476 $ 21 59 (1) Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table. |
Schedule of UL Secondary Guarantees [Table Text Block] | The following table provides information related to insurance guarantees for which the Company has established additional liabilities: March 31, 2017 December 31, 2016 Net Amount at Risk Weighted Average Attained Age Net Amount at Risk Weighted Average Attained Age (in millions, except age) UL secondary guarantees $ 6,407 64 $ 6,376 64 |
Schedule of Changes in Additional Liabilities for Variable Annuity and Insurance Guarantees [Table Text Block] | Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows: GMDB & GGU GMIB GMWB (1) GMAB (1) UL (in millions) Balance at January 1, 2016 $ 14 $ 8 $ 1,057 $ — $ 332 Incurred claims 4 — 649 31 22 Paid claims (4 ) — — — (6 ) Balance at March 31, 2016 $ 14 $ 8 $ 1,706 $ 31 $ 348 Balance at January 1, 2017 $ 16 $ 8 $ 1,017 $ (24 ) $ 434 Incurred claims 1 — (380 ) (29 ) 23 Paid claims (1 ) (1 ) — — (8 ) Balance at March 31, 2017 $ 16 $ 7 $ 637 $ (53 ) $ 449 (1) The incurred claims for GMWB and GMAB represent the change in the fair value of the liabilities (contra liabilities) less paid claims. |
Schedule of Separate Account Balances By Asset Type [Table Text Block] | The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits: March 31, December 31, 2016 (in millions) Mutual funds: Equity $ 42,276 $ 40,622 Bond 23,220 23,142 Other 5,145 5,326 Total mutual funds $ 70,641 $ 69,090 |
Fair Values of Assets and Lia28
Fair Values of Assets and Liabilities (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Schedule of balances of assets and liabilities measured at fair value on a recurring basis [Table Text Block] | The following tables present the balances of assets and liabilities measured at fair value on a recurring basis: March 31, 2017 Level 1 Level 2 Level 3 Total (in millions) Assets Available-for-Sale securities: Fixed maturities: Corporate debt securities $ — $ 12,777 $ 1,185 $ 13,962 Residential mortgage backed securities — 3,186 157 3,343 Commercial mortgage backed securities — 2,751 — 2,751 State and municipal obligations — 1,248 — 1,248 Asset backed securities — 790 49 839 Foreign government bonds and obligations — 264 — 264 U.S. government and agencies obligations 3 — — 3 Total Available-for-Sale securities: Fixed maturities 3 21,016 1,391 22,410 Common stocks 4 — 4 8 Cash equivalents — 316 — 316 Other assets: Interest rate derivative contracts — 1,107 — 1,107 Equity derivative contracts 40 1,580 — 1,620 Credit derivative contracts — 1 — 1 Foreign exchange derivative contracts — 59 — 59 Total other assets 40 2,747 — 2,787 Separate account assets measured at net asset value (“NAV”) 78,053 (1) Total assets at fair value $ 47 $ 24,079 $ 1,395 $ 103,574 Liabilities Policyholder account balances, future policy benefits and claims: EIA embedded derivatives $ — $ 4 $ — $ 4 IUL embedded derivatives — — 493 493 GMWB and GMAB embedded derivatives — — 188 188 (2) Total policyholder account balances, future policy benefits and claims — 4 681 685 (3) Other liabilities: Interest rate derivative contracts 1 461 — 462 Equity derivative contracts 9 2,197 — 2,206 Foreign exchange derivative contracts 1 37 — 38 Other derivative contracts — 4 — 4 Total other liabilities 11 2,699 — 2,710 Total liabilities at fair value $ 11 $ 2,703 $ 681 $ 3,395 December 31, 2016 Level 1 Level 2 Level 3 Total (in millions) Assets Available-for-Sale securities: Fixed maturities: Corporate debt securities $ — $ 12,955 $ 1,157 $ 14,112 Residential mortgage backed securities — 3,300 115 3,415 Commercial mortgage backed securities — 2,857 — 2,857 State and municipal obligations — 1,229 — 1,229 Asset backed securities — 792 13 805 Foreign government bonds and obligations — 261 — 261 U.S. government and agencies obligations 3 — — 3 Total Available-for-Sale securities: Fixed maturities 3 21,394 1,285 22,682 Common stocks 6 4 — 10 Cash equivalents — 302 — 302 Other assets: Interest rate derivative contracts — 1,735 — 1,735 Equity derivative contracts 42 1,481 — 1,523 Credit derivative contracts — 1 — 1 Foreign exchange derivative contracts — 80 — 80 Other derivative contracts 1 6 — 7 Total other assets 43 3,303 — 3,346 Separate account assets measured at NAV 76,298 (1) Total assets at fair value $ 52 $ 25,003 $ 1,285 $ 102,638 Liabilities Policyholder account balances, future policy benefits and claims: EIA embedded derivatives $ — $ 5 $ — $ 5 IUL embedded derivatives — — 464 464 GMWB and GMAB embedded derivatives — — 614 614 (4) Total policyholder account balances, future policy benefits and claims — 5 1,078 1,083 (5) Other liabilities: Interest rate derivative contracts 1 964 — 965 Equity derivative contracts 2 1,986 — 1,988 Foreign exchange derivative contracts 2 45 — 47 Other derivative contracts — 1 — 1 Total other liabilities 5 2,996 — 3,001 Total liabilities at fair value $ 5 $ 3,001 $ 1,078 $ 4,084 (1) Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. (2) The fair value of the GMWB and GMAB embedded derivatives included $585 million of individual contracts in a liability position and $397 million of individual contracts in an asset position as of March 31, 2017 . (3) The Company’s adjustment for nonperformance risk resulted in a $435 million cumulative decrease to the embedded derivatives as of March 31, 2017 . (4) The fair value of the GMWB and GMAB embedded derivatives included $880 million of individual contracts in a liability position and $266 million of individual contracts in an asset position as of December 31, 2016 . (5) The Company’s adjustment for nonperformance risk resulted in a $498 million cumulative decrease to the embedded derivatives as of December 31, 2016 . |
Summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis [Table Text Block] | The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis: Available-for-Sale Securities: Fixed Maturities Corporate Debt Securities Residential Mortgage Backed Securities Asset Backed Securities Common Stocks Total (in millions) Balance, January 1, 2017 $ 1,157 $ 115 $ 13 $ — $ 1,285 Purchases 50 67 49 — 166 Settlements (22 ) (2 ) (13 ) — (37 ) Transfers into Level 3 — — — 4 4 Transfers out of Level 3 — (23 ) — — (23 ) Balance, March 31, 2017 $ 1,185 $ 157 $ 49 $ 4 $ 1,395 Changes in unrealized gains (losses) relating to assets held at March 31, 2017 $ — $ — $ — $ — $ — Policyholder Account Balances, Future Policy Benefits and Claims IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Total (in millions) Balance, January 1, 2017 $ 464 $ 614 $ 1,078 Total (gains) losses included in: Net income 19 (1) (499 ) (2) (480 ) Issues 22 77 99 Settlements (12 ) (4 ) (16 ) Balance, March 31, 2017 $ 493 $ 188 $ 681 Changes in unrealized (gains) losses relating to liabilities held at March 31, 2017 $ 19 (1) $ (484 ) (2) $ (465 ) Available-for-Sale Securities: Fixed Maturities Corporate Debt Securities Residential Mortgage Backed Securities Commercial Mortgage Backed Securities Asset Backed Securities Total (in millions) Balance, January 1, 2016 $ 1,235 $ 21 $ 3 $ 133 $ 1,392 Total gains included in: Other comprehensive income 16 — — — 16 Purchases — — 9 — 9 Settlements (8 ) (2 ) (2 ) — (12 ) Balance, March 31, 2016 $ 1,243 $ 19 $ 10 $ 133 $ 1,405 Changes in unrealized gains (losses) relating to assets held at March 31, 2016 $ — $ — $ — $ — $ — Policyholder Account Balances, Future Policy Benefits and Claims IUL Embedded Derivatives GMWB and GMAB Embedded Derivatives Total (in millions) Balance, January 1, 2016 $ 364 $ 851 $ 1,215 Total (gains) losses included in: Net income (8 ) (1) 602 (2) 594 Issues 32 68 100 Settlements (6 ) (6 ) (12 ) Balance, March 31, 2016 $ 382 $ 1,515 $ 1,897 Changes in unrealized (gains) losses relating to liabilities held at March 31, 2016 $ (8 ) (1) $ 616 (2) $ 608 (1) Included in interest credited to fixed accounts in the Consolidated Statements of Income. (2) Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. |
Significant unobservable inputs used in the fair value measurements [Table Text Block] | The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities: March 31, 2017 Fair Value Valuation Technique Unobservable Input Range Weighted Average (in millions) Corporate debt securities (private placements) $ 1,182 Discounted cash flow Yield/spread to U.S. Treasuries 0.9 % - 2.5% 1.3 % IUL embedded derivatives $ 493 Discounted cash flow Nonperformance risk (1) 80 bps GMWB and GMAB embedded derivatives $ 188 Discounted cash flow Utilization of guaranteed withdrawals (2) 0.0 % - 75.6% Surrender rate 0.1 % - 66.4% Market volatility (3) 5.0 % - 20.0% Nonperformance risk (1) 80 bps December 31, 2016 Fair Value Valuation Technique Unobservable Input Range Weighted Average (in millions) Corporate debt securities (private placements) $ 1,154 Discounted cash flow Yield/spread to U.S. Treasuries 0.9 % - 2.5% 1.3 % IUL embedded derivatives $ 464 Discounted cash flow Nonperformance risk (1) 82 bps GMWB and GMAB embedded derivatives $ 614 Discounted cash flow Utilization of guaranteed withdrawals (2) 0.0 % - 75.6% Surrender rate 0.1 % - 66.4% Market volatility (3) 5.3 % - 21.2% Nonperformance risk (1) 82 bps (1) The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. (2) The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. (3) Market volatility is implied volatility of fund of funds and managed volatility funds. |
Schedule of carrying value and the estimated fair value of financial instruments that are not reported at fair value [Table Text Block] | The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value: March 31, 2017 Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) Financial Assets Mortgage loans, net $ 2,862 $ — $ — $ 2,874 $ 2,874 Policy loans 830 — — 791 791 Other investments 400 — 357 46 403 Financial Liabilities Policyholder account balances, future policy benefits and claims $ 10,715 $ — $ — $ 11,247 $ 11,247 Short-term borrowings 200 — 200 — 200 Other liabilities 171 — — 164 164 Separate account liabilities measured at NAV 347 347 (1) December 31, 2016 Carrying Value Fair Value Level 1 Level 2 Level 3 Total (in millions) Financial Assets Mortgage loans, net $ 2,874 $ — $ — $ 2,865 $ 2,865 Policy loans 830 — — 807 807 Other investments 402 — 364 43 407 Financial Liabilities Policyholder account balances, future policy benefits and claims $ 10,906 $ — $ — $ 11,417 $ 11,417 Short-term borrowings 200 — 200 — 200 Other liabilities 177 — — 169 169 Separate account liabilities measured at NAV 341 341 (1) (1) Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. |
Offsetting Assets and Liabili29
Offsetting Assets and Liabilities (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Offsetting [Abstract] | |
Schedule of Gross and Net Information About the Company's Assets Subject to Master Netting Arrangements [Table Text Block] | The following tables present the gross and net information about the Company’s assets subject to master netting arrangements: March 31, 2017 Gross Amounts of Recognized Assets Gross Amounts Offset in the Consolidated Balance Sheets Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,752 $ — $ 2,752 $ (2,202 ) $ (343 ) $ (201 ) $ 6 OTC cleared (2) 21 — 21 (21 ) — — — Exchange-traded 14 — 14 (2 ) — — 12 Total derivatives $ 2,787 $ — $ 2,787 $ (2,225 ) $ (343 ) $ (201 ) $ 18 December 31, 2016 Gross Amounts of Recognized Assets Gross Amounts Offset in the Consolidated Balance Sheets Amounts of Assets Presented in the Consolidated Balance Sheets Gross Amounts Not Offset Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,822 $ — $ 2,822 $ (2,161 ) $ (374 ) $ (235 ) $ 52 OTC cleared 510 — 510 (507 ) (3 ) — — Exchange-traded 14 — 14 (2 ) — — 12 Total derivatives $ 3,346 $ — $ 3,346 $ (2,670 ) $ (377 ) $ (235 ) $ 64 (1) Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. (2) The decrease in OTC cleared derivatives from December 31, 2016 is a result of certain central clearing parties amending their rules resulting in variation margin payments being settlement payments, as opposed to collateral. |
Schedule of Gross and Net Information About the Company's Liabilities Subject to Master Netting Arrangements [Table Text Block] | The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements: March 31, 2017 Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Consolidated Balance Sheets Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,684 $ — $ 2,684 $ (2,202 ) $ (1 ) $ (460 ) $ 21 OTC cleared (2) 23 — 23 (21 ) — — 2 Exchange-traded 3 — 3 (2 ) — — 1 Total derivatives 2,710 — 2,710 (2,225 ) (1 ) (460 ) 24 Repurchase agreements 50 — 50 — — (50 ) — Total $ 2,760 $ — $ 2,760 $ (2,225 ) $ (1 ) $ (510 ) $ 24 December 31, 2016 Gross Amounts of Recognized Liabilities Gross Amounts Offset in the Consolidated Balance Sheets Amounts of Liabilities Presented in the Consolidated Balance Sheets Gross Amounts Not Offset Net Amount Financial Instruments (1) Cash Collateral Securities Collateral (in millions) Derivatives: OTC $ 2,481 $ — $ 2,481 $ (2,161 ) $ — $ (312 ) $ 8 OTC cleared 515 — 515 (507 ) (8 ) — — Exchange-traded 5 — 5 (2 ) — — 3 Total derivatives 3,001 — 3,001 (2,670 ) (8 ) (312 ) 11 Repurchase agreements 50 — 50 — — (50 ) — Total $ 3,051 $ — $ 3,051 $ (2,670 ) $ (8 ) $ (362 ) $ 11 (1) Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. (2) The decrease in OTC cleared derivatives from December 31, 2016 is a result of certain central clearing parties amending their rules resulting in variation margin payments being settlement payments, as opposed to collateral. |
Derivatives and Hedging Activ30
Derivatives and Hedging Activities (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Gross Fair Value of Derivative Instruments, Including Embedded Derivatives [Table Text Block] | The following table presents the notional value and gross fair value of derivative instruments, including embedded derivatives: March 31, 2017 December 31, 2016 Notional Gross Fair Value Notional Gross Fair Value Assets (1) Liabilities (2) Assets (1) Liabilities (2) (in millions) Derivatives not designated as hedging instruments Interest rate contracts $ 69,800 $ 1,107 $ 462 $ 71,019 $ 1,735 $ 965 Equity contracts 58,967 1,620 2,206 59,401 1,523 1,988 Credit contracts 1,148 1 — 1,039 1 — Foreign exchange contracts 4,520 59 38 4,494 80 47 Other contracts 3,436 — 4 1,258 7 1 Total non-designated hedges 137,871 2,787 2,710 137,211 3,346 3,001 Embedded derivatives GMWB and GMAB (3) N/A — 188 N/A — 614 IUL N/A — 493 N/A — 464 EIA N/A — 4 N/A — 5 Total embedded derivatives N/A — 685 N/A — 1,083 Total derivatives $ 137,871 $ 2,787 $ 3,395 $ 137,211 $ 3,346 $ 4,084 N/A Not applicable. (1) The fair value of freestanding derivative assets is included in Other assets on the Consolidated Balance Sheets. (2) The fair value of freestanding derivative liabilities is included in Other liabilities on the Consolidated Balance Sheets. The fair value of GMWB and GMAB, IUL, and EIA embedded derivatives is included in Policyholder account balances, future policy benefits and claims on the Consolidated Balance Sheets. (3) The fair value of the GMWB and GMAB embedded derivatives as of March 31, 2017 included $585 million of individual contracts in a liability position and $397 million of individual contracts in an asset position. The fair value of the GMWB and GMAB embedded derivatives as of December 31, 2016 included $880 million of individual contracts in a liability position and $266 million of individual contracts in an asset position |
Schedule of Gain (Loss) on Derivative Instruments, Including Embedded Derivatives [Table Text Block] | The following tables present a summary of the impact of derivatives not designated as hedging instruments, including embedded derivatives, on the Consolidated Statements of Income: Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses (in millions) Three Months Ended March 31, 2017 Interest rate contracts $ — $ (75 ) Equity contracts 19 (416 ) Credit contracts — (8 ) Foreign exchange contracts — (24 ) Other contracts — (22 ) GMWB and GMAB embedded derivatives — 426 IUL embedded derivatives (7 ) — Total gain (loss) $ 12 $ (119 ) Interest Credited to Fixed Accounts Benefits, Claims, Losses and Settlement Expenses (in millions) Three Months Ended March 31, 2016 Interest rate contracts $ — $ 755 Equity contracts (3 ) (65 ) Credit contracts — (16 ) Foreign exchange contracts — (35 ) GMWB and GMAB embedded derivatives — (664 ) IUL embedded derivatives 14 — Total gain (loss) $ 11 $ (25 ) |
Schedule of Payments to Make and Receive for Options [Table Text Block] | The following is a summary of the payments the Company is scheduled to make and receive for these options as of March 31, 2017 : Premiums Payable Premiums Receivable (in millions) 2017 (1) $ 210 $ 68 2018 210 129 2019 255 171 2020 176 98 2021 167 107 2022-2026 580 182 Total $ 1,598 $ 755 (1) 2017 amounts represent the amounts payable and receivable for the period from April 1, 2017 to December 31, 2017 . |
Shareholder's Equity (Tables)
Shareholder's Equity (Tables) | 3 Months Ended |
Mar. 31, 2017 | |
Stockholders' Equity Note [Abstract] | |
Schedule of components of OCI [Table Text Block] | The following tables provide the amounts related to each component of OCI: Three Months Ended March 31, 2017 Pretax Income Tax Benefit (Expense) Net of Tax (in millions) Net unrealized securities losses: Net unrealized securities gains arising during the period (1) $ 38 $ (13 ) $ 25 Reclassification of net securities gains included in net income (2) (17 ) 6 (11 ) Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables (26 ) 9 (17 ) Net unrealized securities losses (5 ) 2 (3 ) Net unrealized derivatives gains: Reclassification of net derivative losses included in net income (3) 2 (1 ) 1 Net unrealized derivatives gains 2 (1 ) 1 Other (1 ) — (1 ) Other comprehensive loss $ (4 ) $ 1 $ (3 ) Three Months Ended March 31, 2016 Pretax Income Tax Benefit (Expense) Net of Tax (in millions) Net unrealized securities gains: Net unrealized securities gains arising during the period (1) $ 469 $ (165 ) $ 304 Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables (197 ) 69 (128 ) Net unrealized securities gains 272 (96 ) 176 Net unrealized derivatives gains: Reclassification of net derivative losses included in net income (3) 1 — 1 Net unrealized derivatives gains 1 — 1 Other comprehensive income $ 273 $ (96 ) $ 177 (1) Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income during the period. (2) Reclassification amounts are recorded in net realized investment gains. (3) Reclassification amounts are recorded in net investment income. |
Schedule of amounts reclassified from AOCI [Table Text Block] | The following tables present the changes in the balances of each component of AOCI, net of tax: Net Unrealized Securities Gains Net Unrealized Derivatives Gains Other Total (in millions) Balance, January 1, 2017 $ 461 $ (4 ) $ — $ 457 OCI before reclassifications 8 — (1 ) 7 Amounts reclassified from AOCI (11 ) 1 — (10 ) Total OCI (3 ) 1 (1 ) (3 ) Balance, March 31, 2017 $ 458 (1) $ (3 ) $ (1 ) $ 454 Net Unrealized Securities Gains Net Unrealized Derivatives Gains Total (in millions) Balance, January 1, 2016 $ 403 $ (8 ) $ 395 OCI before reclassifications 176 1 177 Amounts reclassified from AOCI — — — Total OCI 176 1 177 Balance, March 31, 2016 $ 579 (1) $ (7 ) $ 572 (1) Includes $1 million and $(2) million of noncredit related impairments on securities and net unrealized securities gains (losses) on previously impaired securities as of March 31, 2017 and March 31, 2016 , respectively. |
Basis of Presentation (Details)
Basis of Presentation (Details) $ in Millions | 3 Months Ended |
Mar. 31, 2017USD ($)item | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Number of wholly owned subsidiaries | item | 1 |
Quantifying Misstatement in Current Year Financial Statements [Line Items] | |
Quantifying Misstatement in Current Year Financial Statements, Amount | $ (20) |
Income tax provision [Member] | |
Quantifying Misstatement in Current Year Financial Statements [Line Items] | |
Quantifying Misstatement in Current Year Financial Statements, Amount | $ (20) |
Variable Interest Entities Va33
Variable Interest Entities Variable Interest Entities (Details) - VIEs, not primary beneficiary [Member] - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | |
Total fixed maturities [Member] | ||
Variable Interest Entity [Line Items] | ||
Obligation to provide financial or other support to VIEs | $ 0 | |
River Source Tax Advantaged Investments Inc [Member] | ||
Variable Interest Entity [Line Items] | ||
Carrying value of investments reflected in other investments | 481 | $ 482 |
Carrying value of liability of other investments | 134 | $ 135 |
Obligation to provide financial or other support to VIEs | $ 0 |
Investments (AFS by type) (Deta
Investments (AFS by type) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 | |
Investments | |||
Amortized cost | $ 21,173 | $ 21,468 | |
Gross unrealized gains | 1,393 | 1,400 | |
Gross unrealized losses | (148) | (176) | |
Fair value | 22,418 | 22,692 | |
Noncredit OTTI | [1] | 1 | (1) |
Securities owned and pledged as collateral, fair value | 1,400 | 1,500 | |
Amount eligible to be repledged by counterparty | 523 | 428 | |
Corporate debt securities [Member] | |||
Investments | |||
Amortized cost | 12,941 | 13,105 | |
Gross unrealized gains | 1,059 | 1,060 | |
Gross unrealized losses | (38) | (53) | |
Fair value | 13,962 | 14,112 | |
Residential mortgage backed securities [Member] | |||
Investments | |||
Amortized cost | 3,320 | 3,386 | |
Gross unrealized gains | 66 | 72 | |
Gross unrealized losses | (43) | (43) | |
Fair value | 3,343 | 3,415 | |
Noncredit OTTI | [1] | (2) | (4) |
Commercial mortgage backed securities [Member] | |||
Investments | |||
Amortized cost | 2,732 | 2,837 | |
Gross unrealized gains | 55 | 58 | |
Gross unrealized losses | (36) | (38) | |
Fair value | 2,751 | 2,857 | |
State and municipal obligations [Member] | |||
Investments | |||
Amortized cost | 1,102 | 1,092 | |
Gross unrealized gains | 164 | 161 | |
Gross unrealized losses | (18) | (24) | |
Fair value | 1,248 | 1,229 | |
Asset backed securities [Member] | |||
Investments | |||
Amortized cost | 822 | 790 | |
Gross unrealized gains | 25 | 26 | |
Gross unrealized losses | (8) | (11) | |
Fair value | 839 | 805 | |
Foreign government bonds and obligations [Member] | |||
Investments | |||
Amortized cost | 249 | 251 | |
Gross unrealized gains | 20 | 17 | |
Gross unrealized losses | (5) | (7) | |
Fair value | 264 | 261 | |
U.S. government and agencies obligations [Member] | |||
Investments | |||
Amortized cost | 3 | 3 | |
Fair value | 3 | 3 | |
Total fixed maturities [Member] | |||
Investments | |||
Amortized cost | 21,169 | 21,464 | |
Gross unrealized gains | 1,389 | 1,394 | |
Gross unrealized losses | (148) | (176) | |
Fair value | 22,410 | 22,682 | |
Noncredit OTTI | [1] | $ (2) | $ (4) |
Fixed maturity securities as percentage of total investments | 83.00% | 83.00% | |
Fixed maturity investments rated internally | $ 971 | $ 944 | |
Common stocks [Member] | |||
Investments | |||
Amortized cost | 4 | 4 | |
Gross unrealized gains | 4 | 6 | |
Fair value | 8 | 10 | |
Noncredit OTTI | [1] | $ 3 | $ 3 |
[1] | Represents the amount of other-than-temporary impairment (“OTTI”) losses in accumulated other comprehensive income (“AOCI”). Amount includes unrealized gains and losses on impaired securities subsequent to the initial impairment measurement date. These amounts are included in gross unrealized gains and losses as of the end of the period. |
Investments (Rating info) (Deta
Investments (Rating info) (Details) $ in Millions | Mar. 31, 2017USD ($)item | Dec. 31, 2016USD ($)item |
Investments | ||
Amortized cost | $ 21,169 | $ 21,464 |
Fair value | $ 22,410 | $ 22,682 |
Percentage of securities rated AAA that were GNMA, FNMA and FHLMC | 39.00% | 40.00% |
Number of holdings of other than GNMA, FNMA and FHLMC that are greater than 10% of total equity | item | 0 | 0 |
AAA [Member] | ||
Investments | ||
Amortized cost | $ 5,573 | $ 5,671 |
Fair value | $ 5,619 | $ 5,728 |
Percent of total fair value | 25.00% | 25.00% |
AA [Member] | ||
Investments | ||
Amortized cost | $ 1,050 | $ 1,013 |
Fair value | $ 1,220 | $ 1,177 |
Percent of total fair value | 6.00% | 5.00% |
A [Member] | ||
Investments | ||
Amortized cost | $ 3,636 | $ 3,767 |
Fair value | $ 4,040 | $ 4,167 |
Percent of total fair value | 18.00% | 19.00% |
BBB [Member] | ||
Investments | ||
Amortized cost | $ 9,522 | $ 9,584 |
Fair value | $ 10,128 | $ 10,190 |
Percent of total fair value | 45.00% | 45.00% |
Below investment grade [Member] | ||
Investments | ||
Amortized cost | $ 1,388 | $ 1,429 |
Fair value | $ 1,403 | $ 1,420 |
Percent of total fair value | 6.00% | 6.00% |
Total fixed maturities [Member] | ||
Investments | ||
Amortized cost | $ 21,169 | $ 21,464 |
Fair value | $ 22,410 | $ 22,682 |
Percent of total fair value | 100.00% | 100.00% |
Investments (EITF info) (Detail
Investments (EITF info) (Details) $ in Millions | Mar. 31, 2017USD ($)item | Dec. 31, 2016USD ($)item |
Number of Securities | ||
Less than 12 months | item | 282 | 298 |
12 months or more | item | 108 | 119 |
Total | item | 390 | 417 |
Fair Value | ||
Less than 12 months | $ 4,232 | $ 4,489 |
12 months or more | 779 | 896 |
Total | 5,011 | 5,385 |
Unrealized Losses | ||
Less than 12 months | (93) | (98) |
12 months or more | (55) | (78) |
Total | $ (148) | $ (176) |
Corporate debt securities [Member] | ||
Number of Securities | ||
Less than 12 months | item | 102 | 114 |
12 months or more | item | 22 | 33 |
Total | item | 124 | 147 |
Fair Value | ||
Less than 12 months | $ 1,331 | $ 1,502 |
12 months or more | 193 | 319 |
Total | 1,524 | 1,821 |
Unrealized Losses | ||
Less than 12 months | (21) | (26) |
12 months or more | (17) | (27) |
Total | $ (38) | $ (53) |
Residential mortgage backed securities [Member] | ||
Number of Securities | ||
Less than 12 months | item | 65 | 56 |
12 months or more | item | 54 | 56 |
Total | item | 119 | 112 |
Fair Value | ||
Less than 12 months | $ 1,382 | $ 1,282 |
12 months or more | 302 | 324 |
Total | 1,684 | 1,606 |
Unrealized Losses | ||
Less than 12 months | (28) | (25) |
12 months or more | (15) | (18) |
Total | $ (43) | $ (43) |
Commercial mortgage backed securities [Member] | ||
Number of Securities | ||
Less than 12 months | item | 78 | 80 |
12 months or more | item | 2 | 1 |
Total | item | 80 | 81 |
Fair Value | ||
Less than 12 months | $ 1,288 | $ 1,378 |
12 months or more | 13 | 11 |
Total | 1,301 | 1,389 |
Unrealized Losses | ||
Less than 12 months | (36) | (37) |
12 months or more | 0 | (1) |
Total | $ (36) | $ (38) |
State and municipal obligations [Member] | ||
Number of Securities | ||
Less than 12 months | item | 18 | 18 |
12 months or more | item | 2 | 2 |
Total | item | 20 | 20 |
Fair Value | ||
Less than 12 months | $ 71 | $ 66 |
12 months or more | 111 | 105 |
Total | 182 | 171 |
Unrealized Losses | ||
Less than 12 months | (3) | (3) |
12 months or more | (15) | (21) |
Total | $ (18) | $ (24) |
Asset backed securities [Member] | ||
Number of Securities | ||
Less than 12 months | item | 15 | 23 |
12 months or more | item | 14 | 12 |
Total | item | 29 | 35 |
Fair Value | ||
Less than 12 months | $ 150 | $ 231 |
12 months or more | 139 | 114 |
Total | 289 | 345 |
Unrealized Losses | ||
Less than 12 months | (5) | (6) |
12 months or more | (3) | (5) |
Total | $ (8) | $ (11) |
Foreign government bonds and obligations [Member] | ||
Number of Securities | ||
Less than 12 months | item | 4 | 7 |
12 months or more | item | 14 | 15 |
Total | item | 18 | 22 |
Fair Value | ||
Less than 12 months | $ 10 | $ 30 |
12 months or more | 21 | 23 |
Total | 31 | 53 |
Unrealized Losses | ||
Less than 12 months | 0 | (1) |
12 months or more | (5) | (6) |
Total | $ (5) | $ (7) |
Investments Investments (OTTI r
Investments Investments (OTTI rollforward) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Rollforward of the cumulative amounts recognized in the Consolidated Statements of Income for other-than-temporary impairments related to credit losses on securities | ||
Beginning balance | $ 21 | $ 33 |
Credit losses for which an other-than-temporary impairment was previously recognized | 0 | 0 |
Ending balance | $ 21 | $ 33 |
Investments Investments (Realiz
Investments Investments (Realized GL info) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Available-for-sale Securities, Gross Realized Gain (Loss) [Abstract] | ||
Gross realized investment gains | $ 17 | $ 3 |
Gross realized investment losses | 0 | (3) |
Total | $ 17 | $ 0 |
Investments (AFS contractual ma
Investments (AFS contractual maturity) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Amortized Cost | ||
Due within one year | $ 1,035 | |
Due after one year through five years | 5,364 | |
Due after five years through 10 years | 4,157 | |
Due after 10 years | 3,739 | |
Total having single maturity dates | 14,295 | |
Total amortized cost | 21,173 | $ 21,468 |
Fair Value | ||
Due within one year | 1,052 | |
Due after one year through five years | 5,659 | |
Due after five years through 10 years | 4,276 | |
Due after 10 years | 4,490 | |
Total having single maturity dates | 15,477 | |
Total fair value | 22,418 | 22,692 |
Residential mortgage backed securities [Member] | ||
Amortized Cost | ||
Without single maturity dates | 3,320 | |
Total amortized cost | 3,320 | 3,386 |
Fair Value | ||
Without single maturity dates | 3,343 | |
Total fair value | 3,343 | 3,415 |
Commercial mortgage backed securities [Member] | ||
Amortized Cost | ||
Without single maturity dates | 2,732 | |
Total amortized cost | 2,732 | 2,837 |
Fair Value | ||
Without single maturity dates | 2,751 | |
Total fair value | 2,751 | 2,857 |
Asset backed securities [Member] | ||
Amortized Cost | ||
Without single maturity dates | 822 | |
Total amortized cost | 822 | 790 |
Fair Value | ||
Without single maturity dates | 839 | |
Total fair value | 839 | 805 |
Common stocks [Member] | ||
Amortized Cost | ||
Without single maturity dates | 4 | |
Total amortized cost | 4 | 4 |
Fair Value | ||
Without single maturity dates | 8 | |
Total fair value | $ 8 | $ 10 |
Investments (Net Inv Inc summar
Investments (Net Inv Inc summary) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Net Investment Income [Line Items] | ||
Gross investment income | $ 277 | $ 297 |
Less: investment expenses | 6 | 7 |
Total | 271 | 290 |
Fixed maturities [Member] | ||
Net Investment Income [Line Items] | ||
Gross investment income | 242 | 251 |
Mortgage loans [Member] | ||
Net Investment Income [Line Items] | ||
Gross investment income | 35 | 40 |
Other investments [Member] | ||
Net Investment Income [Line Items] | ||
Gross investment income | $ 0 | $ 6 |
Financing Receivables (Allowanc
Financing Receivables (Allowance for Loan Losses) (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 | |
Rollforward of the allowance for loan losses | |||
Beginning balance | $ 25 | $ 25 | |
Provisions | 0 | 1 | |
Ending balance | 25 | 26 | |
Individually evaluated for impairment | 2 | 4 | |
Collectively evaluated for impairment | 23 | 22 | |
Recorded investment in financing receivables by impairment method | |||
Individually evaluated for impairment | 18 | $ 10 | |
Collectively evaluated for impairment | 3,252 | 3,275 | |
Total | 3,270 | 3,285 | |
Recorded investment in financing receivables individually evaluated for impairment with no related allowance for loan losses | 12 | 5 | |
Syndicated Loans [Member] | |||
Recorded investment in financing receivables by impairment method | |||
Total | 390 | 392 | |
Loans purchased | 54 | 13 | |
Residential mortgage loans [Member] | |||
Recorded investment in financing receivables by impairment method | |||
Total | $ 285 | $ 300 | |
Loans sold | 250 | ||
Proceeds from sale of loans | 260 | ||
Gain from sale of loans | $ 10 |
Financing Receivables (Credit Q
Financing Receivables (Credit Quality Information Text) (Details) $ in Millions | Mar. 31, 2017USD ($)item | Dec. 31, 2016USD ($) |
Credit quality information [Line Items] | ||
Total recorded investment, gross | $ 3,270 | $ 3,285 |
90 days or more past due [Member] | ||
Credit quality information [Line Items] | ||
Nonperforming loans | $ 2 | $ 2 |
Commercial mortgage loans [Member] | ||
Credit quality information [Line Items] | ||
Percent of commercial mortgage loans with highest risk rating | 1.00% | 0.00% |
Total recorded investment, gross | $ 2,595 | $ 2,593 |
Residential mortgage loans [Member] | ||
Credit quality information [Line Items] | ||
Total recorded investment, gross | 285 | 300 |
Allowance for loan losses for residential mortgage loans | $ 0 | $ 0 |
Percentage of residential mortgage loans below specific FICO score | 2.00% | 2.00% |
FICO Score | item | 640 | |
Percentage of residential mortgage loans above specific LTV ratio | 0.00% | 0.00% |
LTV Ratio | 90.00% | |
Percentage of residential mortgage loan portfolio represented by state of California | 53.00% | 52.00% |
Percentage of residential mortgage loan portfolio represented by state of Colorado | 17.00% | 18.00% |
Percentage of residential mortgage loan portfolio represented by state of Washington | 13.00% | 13.00% |
Syndicated Loans [Member] | ||
Credit quality information [Line Items] | ||
Total recorded investment, gross | $ 390 | $ 392 |
Syndicated Loans [Member] | 90 days or more past due [Member] | ||
Credit quality information [Line Items] | ||
Nonperforming loans | $ 1 | $ 1 |
Financing Receivables (Credit43
Financing Receivables (Credit Quality Information Tables) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 | Mar. 31, 2016 | Dec. 31, 2015 |
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 3,270 | $ 3,285 | ||
Less: allowance for loan losses | 25 | 25 | $ 26 | $ 25 |
Commercial mortgage loans [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | 2,595 | 2,593 | ||
Less: allowance for loan losses | 19 | 19 | ||
Total loans, net | $ 2,576 | $ 2,574 | ||
Percentage of commercial mortgage loans | 100.00% | 100.00% | ||
Commercial mortgage loans [Member] | Retail [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 897 | $ 916 | ||
Percentage of commercial mortgage loans | 34.00% | 35.00% | ||
Commercial mortgage loans [Member] | Office [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 458 | $ 473 | ||
Percentage of commercial mortgage loans | 18.00% | 18.00% | ||
Commercial mortgage loans [Member] | Apartments [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 511 | $ 483 | ||
Percentage of commercial mortgage loans | 20.00% | 19.00% | ||
Commercial mortgage loans [Member] | Industrial [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 436 | $ 430 | ||
Percentage of commercial mortgage loans | 17.00% | 17.00% | ||
Commercial mortgage loans [Member] | Mixed use [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 44 | $ 42 | ||
Percentage of commercial mortgage loans | 2.00% | 2.00% | ||
Commercial mortgage loans [Member] | Hotel [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 41 | $ 41 | ||
Percentage of commercial mortgage loans | 1.00% | 1.00% | ||
Commercial mortgage loans [Member] | Other [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 208 | $ 208 | ||
Percentage of commercial mortgage loans | 8.00% | 8.00% | ||
Commercial mortgage loans [Member] | South Atlantic [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 760 | $ 753 | ||
Percentage of commercial mortgage loans | 29.00% | 29.00% | ||
Commercial mortgage loans [Member] | Pacific [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 714 | $ 722 | ||
Percentage of commercial mortgage loans | 28.00% | 28.00% | ||
Commercial mortgage loans [Member] | Mountain [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 235 | $ 234 | ||
Percentage of commercial mortgage loans | 9.00% | 9.00% | ||
Commercial mortgage loans [Member] | West North Central [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 213 | $ 212 | ||
Percentage of commercial mortgage loans | 8.00% | 8.00% | ||
Commercial mortgage loans [Member] | Middle Atlantic [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 188 | $ 191 | ||
Percentage of commercial mortgage loans | 7.00% | 7.00% | ||
Commercial mortgage loans [Member] | East North Central [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 200 | $ 195 | ||
Percentage of commercial mortgage loans | 8.00% | 8.00% | ||
Commercial mortgage loans [Member] | West South Central [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 124 | $ 122 | ||
Percentage of commercial mortgage loans | 5.00% | 5.00% | ||
Commercial mortgage loans [Member] | New England [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 82 | $ 84 | ||
Percentage of commercial mortgage loans | 3.00% | 3.00% | ||
Commercial mortgage loans [Member] | East South Central [Member] | ||||
Commercial mortgage loans [Line Items] | ||||
Total loans, gross | $ 79 | $ 80 | ||
Percentage of commercial mortgage loans | 3.00% | 3.00% |
Financing Receivables (Troubled
Financing Receivables (Troubled Debt Restructurings) (Details) - USD ($) | Mar. 31, 2017 | Mar. 31, 2016 |
Receivables [Abstract] | ||
Commitments to lend additional funds to borrowers for restructured loans | $ 0 | $ 0 |
Deferred Acquisition Costs an45
Deferred Acquisition Costs and Deferred Sales Inducement Costs (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | ||
Balances of and changes in DAC | |||
Balance at the beginning of the period | $ 2,611 | $ 2,693 | [1] |
Capitalization of acquisition costs | 54 | 63 | |
Amortization | (57) | (90) | |
Impact of change in net unrealized securities gains | 0 | (47) | |
Balance at the end of the period | 2,608 | 2,619 | [1] |
Balances of and changes in DSIC | |||
Balance at the beginning of the period | 301 | 334 | |
Capitalization of sales inducement costs | 2 | 1 | |
Amortization | (10) | (12) | |
Impact of change in net unrealized securities gains | 0 | (8) | |
Balance at the end of the period | $ 293 | $ 315 | |
[1] | DAC balances were restated for the correction of commission expense accrual for certain insurance and annuity products in the fourth quarter of 2016. See Note 1 in the 2016 10-K. |
Policyholder Account Balances46
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Balances by product) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 | |
Policyholder account balances | $ 20,497 | $ 20,618 | |
Future policy benefits | 8,368 | 8,700 | |
Policy claims and other policyholders’ funds | 202 | 196 | |
Total Policyholder account balances, future policy benefits and claims | 29,067 | 29,514 | |
Fixed annuities [Member] | |||
Policyholder account balances | 10,400 | 10,588 | |
Variable annuity fixed sub-accounts [Member] | |||
Policyholder account balances | 5,212 | 5,211 | |
VUL/UL insurance [Member] | |||
Policyholder account balances | 3,011 | 3,007 | |
IUL [Member] | |||
Policyholder account balances | 1,127 | 1,054 | |
Other life Insurance [Member] | |||
Policyholder account balances | 747 | 758 | |
Variable annuity GMWB [Member] | |||
Future policy benefits | 637 | 1,017 | |
Variable annuity GMAB [Member] | |||
Future policy benefits | [1] | (53) | (24) |
Other annuity liabilities [Member] | |||
Future policy benefits | 71 | 66 | |
Fixed annuities life contingent liabilities [Member] | |||
Future policy benefits | 1,488 | 1,497 | |
Llife, disability income and long term care insurance [Member] | |||
Future policy benefits | 5,610 | 5,556 | |
VUL/UL and other life insurance additional liabilities [Member] | |||
Future policy benefits | $ 615 | $ 588 | |
[1] | Includes the fair value of GMAB embedded derivatives that was a net asset as of both March 31, 2017 and December 31, 2016 reported as a contra liability. |
Policyholder Account Balances47
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Separate Account Liabilities) (Details 2) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Separate Accounts Disclosure [Abstract] | ||
Variable annuity | $ 71,154 | $ 69,606 |
VUL insurance | 6,867 | 6,659 |
Other insurance | 32 | 33 |
Total | $ 78,053 | $ 76,298 |
Variable Annuity and Insuranc48
Variable Annuity and Insurance Guarantees (VA guarantee details) (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | ||
GMDB [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 75,490 | $ 73,954 |
Contract value in separate accounts | [1] | 70,329 | 68,790 |
Net amount at risk | [1] | $ 172 | $ 433 |
Weighted average attained age | [1] | 66 years | 65 years |
GMDB [Member] | Return of premium [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 57,540 | $ 56,143 |
Contract value in separate accounts | [1] | 55,555 | 54,145 |
Net amount at risk | [1] | $ 50 | $ 208 |
Weighted average attained age | [1] | 66 years | 65 years |
GMDB [Member] | Five/six-year reset [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 8,919 | $ 8,878 |
Contract value in separate accounts | [1] | 6,198 | 6,170 |
Net amount at risk | [1] | $ 16 | $ 22 |
Weighted average attained age | [1] | 66 years | 66 years |
GMDB [Member] | One-year ratchet [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 6,474 | $ 6,426 |
Contract value in separate accounts | [1] | 6,102 | 6,050 |
Net amount at risk | [1] | $ 33 | $ 110 |
Weighted average attained age | [1] | 68 years | 68 years |
GMDB [Member] | Five-year ratchet [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 1,560 | $ 1,542 |
Contract value in separate accounts | [1] | 1,501 | 1,483 |
Net amount at risk | [1] | $ 2 | $ 7 |
Weighted average attained age | [1] | 64 years | 64 years |
GMDB [Member] | Other [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 997 | $ 965 |
Contract value in separate accounts | [1] | 973 | 942 |
Net amount at risk | [1] | $ 71 | $ 86 |
Weighted average attained age | [1] | 71 years | 71 years |
GGU death benefit [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 1,070 | $ 1,047 |
Contract value in separate accounts | [1] | 1,019 | 996 |
Net amount at risk | [1] | $ 115 | $ 108 |
Weighted average attained age | [1] | 69 years | 68 years |
GMIB [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 240 | $ 245 |
Contract value in separate accounts | [1] | 222 | 227 |
Net amount at risk | [1] | $ 9 | $ 13 |
Weighted average attained age | [1] | 68 years | 68 years |
GMWB [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 43,344 | $ 42,086 |
Contract value in separate accounts | [1] | 43,201 | 41,924 |
Net amount at risk | [1] | $ 223 | $ 497 |
Weighted average attained age | [1] | 66 years | 66 years |
GMWB [Member] | GMWB [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 2,615 | $ 2,650 |
Contract value in separate accounts | [1] | 2,607 | 2,642 |
Net amount at risk | [1] | $ 2 | $ 2 |
Weighted average attained age | [1] | 70 years | 70 years |
GMWB [Member] | GMWB for life [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 40,729 | $ 39,436 |
Contract value in separate accounts | [1] | 40,594 | 39,282 |
Net amount at risk | [1] | $ 221 | $ 495 |
Weighted average attained age | [1] | 66 years | 66 years |
GMAB [Member] | |||
Variable Annuity Guarantees by Benefit Type | |||
Total contract value | [1] | $ 3,385 | $ 3,484 |
Contract value in separate accounts | [1] | 3,378 | 3,476 |
Net amount at risk | [1] | $ 4 | $ 21 |
Weighted average attained age | [1] | 59 years | 59 years |
[1] | Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table. |
Variable Annuity and Insuranc49
Variable Annuity and Insurance Guarantees Variable Annuity and Insurance Guarantees (UL Secondary Guarantees) (Details) - UL secondary guarantees [Member] - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2017 | Dec. 31, 2016 | |
Insurance Guarantees by Benefit Type | ||
Net amount at risk | $ 6,407 | $ 6,376 |
Weighted average attained age | 64 years | 64 years |
Variable Annuity and Insuranc50
Variable Annuity and Insurance Guarantees (Liability rollforward) (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | ||
GMDB & GGU [Member] | |||
Changes in additional liabilities for variable annuity and insurance guarantees | |||
Balance at the beginning of the period | $ 16 | $ 14 | |
Incurred claims | 1 | 4 | |
Paid claims | (1) | (4) | |
Balance at the end of the period | 16 | 14 | |
GMIB [Member] | |||
Changes in additional liabilities for variable annuity and insurance guarantees | |||
Balance at the beginning of the period | 8 | 8 | |
Paid claims | (1) | ||
Balance at the end of the period | 7 | 8 | |
GMWB [Member] | |||
Changes in additional liabilities for variable annuity and insurance guarantees | |||
Balance at the beginning of the period | [1] | 1,017 | 1,057 |
Incurred claims | [1] | (380) | 649 |
Balance at the end of the period | [1] | 637 | 1,706 |
GMAB [Member] | |||
Changes in additional liabilities for variable annuity and insurance guarantees | |||
Balance at the beginning of the period | [1] | (24) | 0 |
Incurred claims | [1] | (29) | 31 |
Balance at the end of the period | [1] | (53) | 31 |
UL [Member] | |||
Changes in additional liabilities for variable annuity and insurance guarantees | |||
Balance at the beginning of the period | 434 | 332 | |
Incurred claims | 23 | 22 | |
Paid claims | (8) | (6) | |
Balance at the end of the period | $ 449 | $ 348 | |
[1] | The incurred claims for GMWB and GMAB represent the change in the fair value of the liabilities (contra liabilities) less paid claims. |
Variable Annuity and Insuranc51
Variable Annuity and Insurance Guarantees (Separate account balance by type) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 |
Mutual funds | ||
Variable Annuity and Insurance Guarantees | ||
Total mutual funds | $ 70,641 | $ 69,090 |
Equity [Member] | ||
Variable Annuity and Insurance Guarantees | ||
Total mutual funds | 42,276 | 40,622 |
Bond [Member] | ||
Variable Annuity and Insurance Guarantees | ||
Total mutual funds | 23,220 | 23,142 |
Other [Member] | ||
Variable Annuity and Insurance Guarantees | ||
Total mutual funds | $ 5,145 | $ 5,326 |
Short-term Borrowings (Details)
Short-term Borrowings (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2017 | Dec. 31, 2016 | |
Borrowings | ||
Amount of the liability including accrued interest | $ 200 | $ 200 |
Repurchase agreements [Member] | ||
Borrowings | ||
Amount of the liability including accrued interest | $ 50 | $ 50 |
Remaining maturity of outstanding amount for short-term borrowings | 4 months | 3 months |
Weighted average annualized interest rate | 1.10% | 0.90% |
Federal Home Loan Bank [Member] | ||
Borrowings | ||
Amount of the liability including accrued interest | $ 150 | $ 150 |
Remaining maturity of outstanding amount for short-term borrowings | 3 months | 4 months |
Weighted average annualized interest rate | 0.80% | 0.80% |
Residential mortgage backed securities [Member] | Repurchase agreements [Member] | ||
Borrowings | ||
Fair value of securities pledged | $ 33 | $ 33 |
Commercial mortgage backed securities [Member] | Repurchase agreements [Member] | ||
Borrowings | ||
Fair value of securities pledged | 19 | 19 |
Commercial mortgage backed securities [Member] | Federal Home Loan Bank [Member] | ||
Borrowings | ||
Fair value of securities pledged | $ 769 | $ 771 |
Fair Values of Assets and Lia53
Fair Values of Assets and Liabilities (Assets & liabilities reported at FV) (Details) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |||
Mar. 31, 2017 | Dec. 31, 2016 | ||||
Assets and liabilities measured at fair value | |||||
Liability | [1] | $ 3,395 | $ 4,084 | ||
Asset | [2] | 2,787 | 3,346 | ||
Cumulative decrease in embedded derivatives due to nonperformance | (435) | (498) | |||
Assets | |||||
Available-for-sale securities: fixed maturities | 22,410 | 22,682 | |||
Common stocks | 8 | 10 | |||
Separate account assets measured at NAV | 78,053 | 76,298 | |||
GMWB and GMAB embedded derivatives [Member] | |||||
Assets and liabilities measured at fair value | |||||
Liability | 585 | 880 | |||
Asset | 397 | 266 | |||
Recurring basis [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 22,410 | 22,682 | |||
Common stocks | 8 | 10 | |||
Cash equivalents | 316 | 302 | |||
Other assets | 2,787 | 3,346 | |||
Separate account assets measured at NAV | [3] | 78,053 | 76,298 | ||
Total assets at fair value | 103,574 | 102,638 | |||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 685 | [4] | 1,083 | [5] | |
Other liabilities | 2,710 | 3,001 | |||
Total liabilities at fair value | 3,395 | 4,084 | |||
Recurring basis [Member] | Interest rate derivative contracts [Member] | |||||
Assets | |||||
Other assets | 1,107 | 1,735 | |||
Liabilities | |||||
Other liabilities | 462 | 965 | |||
Recurring basis [Member] | Equity derivative contracts [Member] | |||||
Assets | |||||
Other assets | 1,620 | 1,523 | |||
Liabilities | |||||
Other liabilities | 2,206 | 1,988 | |||
Recurring basis [Member] | Credit derivative contracts [Member] | |||||
Assets | |||||
Other assets | 1 | 1 | |||
Recurring basis [Member] | Foreign exchange derivatives contracts [Member] | |||||
Assets | |||||
Other assets | 59 | 80 | |||
Liabilities | |||||
Other liabilities | 38 | 47 | |||
Recurring basis [Member] | Other derivative contracts [Member] | |||||
Assets | |||||
Other assets | 7 | ||||
Liabilities | |||||
Other liabilities | 4 | 1 | |||
Recurring basis [Member] | EIA embedded derivatives [Member] | |||||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 4 | 5 | |||
Recurring basis [Member] | IUL embedded derivatives [Member] | |||||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 493 | 464 | |||
Recurring basis [Member] | GMWB and GMAB embedded derivatives [Member] | |||||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 188 | [6] | 614 | [7] | |
Recurring basis [Member] | Corporate debt securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 13,962 | 14,112 | |||
Recurring basis [Member] | Residential mortgage backed securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 3,343 | 3,415 | |||
Recurring basis [Member] | Commercial mortgage backed securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 2,751 | 2,857 | |||
Recurring basis [Member] | State and municipal obligations [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 1,248 | 1,229 | |||
Recurring basis [Member] | Asset backed securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 839 | 805 | |||
Recurring basis [Member] | Foreign government bonds and obligations [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 264 | 261 | |||
Recurring basis [Member] | U.S. government and agencies obligations [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 3 | 3 | |||
Recurring basis [Member] | Level 1 [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 3 | 3 | |||
Common stocks | 4 | 6 | |||
Other assets | 40 | 43 | |||
Total assets at fair value | 47 | 52 | |||
Liabilities | |||||
Other liabilities | 11 | 5 | |||
Total liabilities at fair value | 11 | 5 | |||
Recurring basis [Member] | Level 1 [Member] | Interest rate derivative contracts [Member] | |||||
Liabilities | |||||
Other liabilities | 1 | 1 | |||
Recurring basis [Member] | Level 1 [Member] | Equity derivative contracts [Member] | |||||
Assets | |||||
Other assets | 40 | 42 | |||
Liabilities | |||||
Other liabilities | 9 | 2 | |||
Recurring basis [Member] | Level 1 [Member] | Foreign exchange derivatives contracts [Member] | |||||
Liabilities | |||||
Other liabilities | 1 | 2 | |||
Recurring basis [Member] | Level 1 [Member] | Other derivative contracts [Member] | |||||
Assets | |||||
Other assets | 1 | ||||
Recurring basis [Member] | Level 1 [Member] | U.S. government and agencies obligations [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 3 | 3 | |||
Recurring basis [Member] | Level 2 [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 21,016 | 21,394 | |||
Common stocks | 4 | ||||
Cash equivalents | 316 | 302 | |||
Other assets | 2,747 | 3,303 | |||
Total assets at fair value | 24,079 | 25,003 | |||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 4 | 5 | |||
Other liabilities | 2,699 | 2,996 | |||
Total liabilities at fair value | 2,703 | 3,001 | |||
Recurring basis [Member] | Level 2 [Member] | Interest rate derivative contracts [Member] | |||||
Assets | |||||
Other assets | 1,107 | 1,735 | |||
Liabilities | |||||
Other liabilities | 461 | 964 | |||
Recurring basis [Member] | Level 2 [Member] | Equity derivative contracts [Member] | |||||
Assets | |||||
Other assets | 1,580 | 1,481 | |||
Liabilities | |||||
Other liabilities | 2,197 | 1,986 | |||
Recurring basis [Member] | Level 2 [Member] | Credit derivative contracts [Member] | |||||
Assets | |||||
Other assets | 1 | 1 | |||
Recurring basis [Member] | Level 2 [Member] | Foreign exchange derivatives contracts [Member] | |||||
Assets | |||||
Other assets | 59 | 80 | |||
Liabilities | |||||
Other liabilities | 37 | 45 | |||
Recurring basis [Member] | Level 2 [Member] | Other derivative contracts [Member] | |||||
Assets | |||||
Other assets | 6 | ||||
Liabilities | |||||
Other liabilities | 4 | 1 | |||
Recurring basis [Member] | Level 2 [Member] | EIA embedded derivatives [Member] | |||||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 4 | 5 | |||
Recurring basis [Member] | Level 2 [Member] | Corporate debt securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 12,777 | 12,955 | |||
Recurring basis [Member] | Level 2 [Member] | Residential mortgage backed securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 3,186 | 3,300 | |||
Recurring basis [Member] | Level 2 [Member] | Commercial mortgage backed securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 2,751 | 2,857 | |||
Recurring basis [Member] | Level 2 [Member] | State and municipal obligations [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 1,248 | 1,229 | |||
Recurring basis [Member] | Level 2 [Member] | Asset backed securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 790 | 792 | |||
Recurring basis [Member] | Level 2 [Member] | Foreign government bonds and obligations [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 264 | 261 | |||
Recurring basis [Member] | Level 3 [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 1,391 | 1,285 | |||
Common stocks | 4 | ||||
Total assets at fair value | 1,395 | 1,285 | |||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 681 | 1,078 | |||
Total liabilities at fair value | 681 | 1,078 | |||
Recurring basis [Member] | Level 3 [Member] | IUL embedded derivatives [Member] | |||||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 493 | 464 | |||
Recurring basis [Member] | Level 3 [Member] | GMWB and GMAB embedded derivatives [Member] | |||||
Liabilities | |||||
Policyholder account balances, future policy benefits and claims | 188 | 614 | |||
Recurring basis [Member] | Level 3 [Member] | Corporate debt securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 1,185 | 1,157 | |||
Recurring basis [Member] | Level 3 [Member] | Residential mortgage backed securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | 157 | 115 | |||
Recurring basis [Member] | Level 3 [Member] | Asset backed securities [Member] | |||||
Assets | |||||
Available-for-sale securities: fixed maturities | $ 49 | $ 13 | |||
[1] | The fair value of freestanding derivative liabilities is included in Other liabilities on the Consolidated Balance Sheets. The fair value of GMWB and GMAB, IUL, and EIA embedded derivatives is included in Policyholder account balances, future policy benefits and claims on the Consolidated Balance Sheets. | ||||
[2] | The fair value of freestanding derivative assets is included in Other assets on the Consolidated Balance Sheets. | ||||
[3] | Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. | ||||
[4] | The Company’s adjustment for nonperformance risk resulted in a $435 million cumulative decrease to the embedded derivatives as of March 31, 2017. | ||||
[5] | The Company’s adjustment for nonperformance risk resulted in a $498 million cumulative decrease to the embedded derivatives as of December 31, 2016. | ||||
[6] | The fair value of the GMWB and GMAB embedded derivatives included $585 million of individual contracts in a liability position and $397 million of individual contracts in an asset position as of March 31, 2017. | ||||
[7] | The fair value of the GMWB and GMAB embedded derivatives included $880 million of individual contracts in a liability position and $266 million of individual contracts in an asset position as of December 31, 2016. |
Fair Values of Assets and Lia54
Fair Values of Assets and Liabilities (Level 3 rollforwards-Assets) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||
Transfers from Level 1 to Level 2, assets | $ 0 | $ 0 |
Transfers from Level 2 to Level 1, assets | 0 | 0 |
Corporate debt securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 1,157 | 1,235 |
Total gains included in other comprehensive income | 16 | |
Purchases | 50 | |
Settlements | (22) | (8) |
Balance, at the end of the period | 1,185 | 1,243 |
Residential mortgage backed securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 115 | 21 |
Purchases | 67 | |
Settlements | (2) | (2) |
Transfers out of Level 3 | (23) | |
Balance, at the end of the period | 157 | 19 |
Commercial mortgage backed securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 3 | |
Purchases | 9 | |
Settlements | (2) | |
Balance, at the end of the period | 10 | |
Asset backed securities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 13 | 133 |
Purchases | 49 | |
Settlements | (13) | |
Balance, at the end of the period | 49 | 133 |
Common stocks [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 0 | |
Transfers into Level 3 | 4 | |
Balance, at the end of the period | 4 | |
Available-for-sale securities: fixed maturities [Member] | ||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ||
Balance, at the beginning of the period | 1,285 | 1,392 |
Total gains included in other comprehensive income | 16 | |
Purchases | 166 | 9 |
Settlements | (37) | (12) |
Transfers into Level 3 | 4 | |
Transfers out of Level 3 | (23) | |
Balance, at the end of the period | 1,395 | 1,405 |
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings [Abstract] | ||
Changes in unrealized gains (losses) relating to assets held at end of period | $ 0 | $ 0 |
Fair Values of Assets and Lia55
Fair Values of Assets and Liabilities (Level 3 rollforwards-Liabilities) (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | ||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||
Net increase (decrease) to pretax income from embedded derivative liability | $ (45) | $ 189 | |
Transfers from Level 1 to Level 2, liabilities | 0 | 0 | |
Transfers from Level 2 to Level 1, liabilities | 0 | 0 | |
IUL embedded derivatives [Member] | |||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | |||
Balance at the beginning of the period | 464 | 364 | |
Total (gains) losses included in net income | [1] | 19 | (8) |
Issues | 22 | 32 | |
Settlements | (12) | (6) | |
Balance at the end of the period | 493 | 382 | |
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings [Abstract] | |||
Changes in unrealized (gains) losses relating to liabilities held at the end of the period | [1] | 19 | (8) |
GMWB and GMAB embedded derivatives [Member] | |||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | |||
Balance at the beginning of the period | 614 | 851 | |
Total (gains) losses included in net income | [2] | (499) | 602 |
Issues | 77 | 68 | |
Settlements | (4) | (6) | |
Balance at the end of the period | 188 | 1,515 | |
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings [Abstract] | |||
Changes in unrealized (gains) losses relating to liabilities held at the end of the period | [2] | (484) | 616 |
Total [Member] | |||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | |||
Balance at the beginning of the period | 1,078 | 1,215 | |
Total (gains) losses included in net income | (480) | 594 | |
Issues | 99 | 100 | |
Settlements | (16) | (12) | |
Balance at the end of the period | 681 | 1,897 | |
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings [Abstract] | |||
Changes in unrealized (gains) losses relating to liabilities held at the end of the period | $ (465) | $ 608 | |
[1] | Included in interest credited to fixed accounts in the Consolidated Statements of Income. | ||
[2] | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. |
Fair Values of Assets and Lia56
Fair Values of Assets and Liabilities (Unobservable inputs) (Details) - Discounted cash flow technique [Member] - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | ||
IUL embedded derivatives [Member] | |||
Fair values of assets and liabilities | |||
Liabilities at fair value | $ 493 | $ 464 | |
Nonperformance risk (as a percent) | [1] | 0.80% | 0.82% |
GMWB and GMAB embedded derivatives [Member] | |||
Fair values of assets and liabilities | |||
Liabilities at fair value | $ 188 | $ 614 | |
Nonperformance risk (as a percent) | [1] | 0.80% | 0.82% |
GMWB and GMAB embedded derivatives [Member] | Minimum [Member] | |||
Fair values of assets and liabilities | |||
Utilization of guaranteed withdrawals (as a percent) | [2] | 0.00% | 0.00% |
Surrender rate (as a percent) | 0.10% | 0.10% | |
Market volatility rate (as a percent) | [3] | 5.00% | 5.30% |
GMWB and GMAB embedded derivatives [Member] | Maximum [Member] | |||
Fair values of assets and liabilities | |||
Utilization of guaranteed withdrawals (as a percent) | [2] | 75.60% | 75.60% |
Surrender rate (as a percent) | 66.40% | 66.40% | |
Market volatility rate (as a percent) | [3] | 20.00% | 21.20% |
Corporate debt securities [Member] | |||
Fair values of assets and liabilities | |||
Assets at fair value | $ 1,182 | $ 1,154 | |
Corporate debt securities [Member] | Minimum [Member] | |||
Fair values of assets and liabilities | |||
Yield/spread to U.S. Treasuries (as a percent) | 0.90% | 0.90% | |
Corporate debt securities [Member] | Maximum [Member] | |||
Fair values of assets and liabilities | |||
Yield/spread to U.S. Treasuries (as a percent) | 2.50% | 2.50% | |
Corporate debt securities [Member] | Weighted average [Member] | |||
Fair values of assets and liabilities | |||
Yield/spread to U.S. Treasuries (as a percent) | 1.30% | 1.30% | |
[1] | The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. | ||
[2] | The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. | ||
[3] | Market volatility is implied volatility of fund of funds and managed volatility funds. |
Fair Values of Assets and Lia57
Fair Values of Assets and Liabilities (Financial Instruments not at FV) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 | |
Financial Assets | |||
Mortgage loans, net | $ 2,862 | $ 2,874 | |
Policy loans | 830 | 830 | |
Other investments | 992 | 998 | |
Financial Liabilities | |||
Policyholder account balances, future policy benefits and claims | 29,067 | 29,514 | |
Short-term borrowings | 200 | 200 | |
Other liabilities | 3,866 | 4,253 | |
Separate account liabilities measured at NAV | 78,053 | 76,298 | |
Carrying value [Member] | |||
Financial Assets | |||
Mortgage loans, net | 2,862 | 2,874 | |
Policy loans | 830 | 830 | |
Other investments | 400 | 402 | |
Financial Liabilities | |||
Policyholder account balances, future policy benefits and claims | 10,715 | 10,906 | |
Short-term borrowings | 200 | 200 | |
Other liabilities | 171 | 177 | |
Separate account liabilities measured at NAV | 347 | 341 | |
Recurring basis [Member] | |||
Financial Assets | |||
Mortgage loans, net | 2,874 | 2,865 | |
Policy loans | 791 | 807 | |
Other investments | 403 | 407 | |
Financial Liabilities | |||
Policyholder account balances, future policy benefits and claims | 11,247 | 11,417 | |
Short-term borrowings | 200 | 200 | |
Other liabilities | 164 | 169 | |
Separate account liabilities measured at NAV | [1] | 347 | 341 |
Recurring basis [Member] | Level 2 [Member] | |||
Financial Assets | |||
Other investments | 357 | 364 | |
Financial Liabilities | |||
Short-term borrowings | 200 | 200 | |
Recurring basis [Member] | Level 3 [Member] | |||
Financial Assets | |||
Mortgage loans, net | 2,874 | 2,865 | |
Policy loans | 791 | 807 | |
Other investments | 46 | 43 | |
Financial Liabilities | |||
Policyholder account balances, future policy benefits and claims | 11,247 | 11,417 | |
Other liabilities | $ 164 | $ 169 | |
[1] | (1) Amounts are comprised of certain investments that are measured at fair value using the NAV per share (or its equivalent) as a practical expedient and have not been classified in the fair value hierarchy. |
Offsetting Assets and Liabili58
Offsetting Assets and Liabilities (Assets) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 | ||
Derivatives: | ||||
Asset | [1] | $ 2,787 | $ 3,346 | |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (2,225) | (2,670) | |
Cash collateral | (343) | (377) | ||
Securities collateral | (201) | (235) | ||
Net amount | 18 | 64 | ||
OTC derivatives [Member] | ||||
Derivatives: | ||||
Asset | 2,752 | 2,822 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (2,202) | (2,161) | |
Cash collateral | (343) | (374) | ||
Securities collateral | (201) | (235) | ||
Net amount | 6 | 52 | ||
OTC cleared derivatives [Member] | ||||
Derivatives: | ||||
Asset | 21 | [3] | 510 | |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (21) | [3] | (507) |
Cash collateral | (3) | |||
Net amount | 0 | 0 | ||
Exchange-traded derivatives [Member] | ||||
Derivatives: | ||||
Asset | 14 | 14 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (2) | (2) | |
Net amount | $ 12 | $ 12 | ||
[1] | The fair value of freestanding derivative assets is included in Other assets on the Consolidated Balance Sheets. | |||
[2] | Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. | |||
[3] | The decrease in OTC cleared derivatives from December 31, 2016 is a result of certain central clearing parties amending their rules resulting in variation margin payments being settlement payments, as opposed to collateral. |
Offsetting Assets and Liabili59
Offsetting Assets and Liabilities (Liabilities) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 | ||
Derivatives | ||||
Liability | [1] | $ 3,395 | $ 4,084 | |
Repurchase agreements | ||||
Gross amounts of recognized liabilities | 50 | 50 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Securities collateral | (50) | (50) | ||
Net amount | 0 | 0 | ||
Total | ||||
Gross amounts of recognized liabilities | 2,760 | 3,051 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (2,225) | (2,670) | |
Cash collateral | (1) | (8) | ||
Securities collateral | (510) | (362) | ||
Net amount | 24 | 11 | ||
OTC derivatives [Member] | ||||
Derivatives | ||||
Liability | 2,684 | 2,481 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (2,202) | (2,161) | |
Cash collateral | (1) | |||
Securities collateral | (460) | (312) | ||
Net amount | 21 | 8 | ||
OTC cleared derivatives [Member] | ||||
Derivatives | ||||
Liability | 23 | [3] | 515 | |
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (21) | [3] | (507) |
Cash collateral | (8) | |||
Net amount | 2 | 0 | ||
Exchange-traded derivatives [Member] | ||||
Derivatives | ||||
Liability | 3 | 5 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (2) | (2) | |
Net amount | 1 | 3 | ||
Total derivatives [Member] | ||||
Derivatives | ||||
Liability | 2,710 | 3,001 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ||||
Financial instruments | [2] | (2,225) | (2,670) | |
Cash collateral | (1) | (8) | ||
Securities collateral | (460) | (312) | ||
Net amount | $ 24 | $ 11 | ||
[1] | The fair value of freestanding derivative liabilities is included in Other liabilities on the Consolidated Balance Sheets. The fair value of GMWB and GMAB, IUL, and EIA embedded derivatives is included in Policyholder account balances, future policy benefits and claims on the Consolidated Balance Sheets. | |||
[2] | Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. | |||
[3] | The decrease in OTC cleared derivatives from December 31, 2016 is a result of certain central clearing parties amending their rules resulting in variation margin payments being settlement payments, as opposed to collateral. |
Derivatives and Hedging Activ60
Derivatives and Hedging Activities (Balance Sheet) (Details) - USD ($) $ in Millions | Mar. 31, 2017 | Dec. 31, 2016 | |
Derivatives and Hedging Activities | |||
Notional amount | $ 137,871 | $ 137,211 | |
Asset | [1] | 2,787 | 3,346 |
Liability | [2] | 3,395 | 4,084 |
Fair value of investment securities received as collateral | 229 | 235 | |
Fair value of investment securities received as collateral that can be repledged | 124 | 118 | |
Fair value of investment securities received as collateral that were repledged | 14 | 19 | |
GMWB and GMAB embedded derivatives [Member] | |||
Derivatives and Hedging Activities | |||
Asset | 397 | 266 | |
Liability | 585 | 880 | |
Derivatives not designated as hedging instruments [Member] | |||
Derivatives and Hedging Activities | |||
Notional amount | 137,871 | 137,211 | |
Derivatives not designated as hedging instruments [Member] | Interest rate contracts [Member] | |||
Derivatives and Hedging Activities | |||
Notional amount | 69,800 | 71,019 | |
Derivatives not designated as hedging instruments [Member] | Equity contracts [Member] | |||
Derivatives and Hedging Activities | |||
Notional amount | 58,967 | 59,401 | |
Derivatives not designated as hedging instruments [Member] | Credit contracts [Member] | |||
Derivatives and Hedging Activities | |||
Notional amount | 1,148 | 1,039 | |
Derivatives not designated as hedging instruments [Member] | Foreign exchange contracts [Member] | |||
Derivatives and Hedging Activities | |||
Notional amount | 4,520 | 4,494 | |
Derivatives not designated as hedging instruments [Member] | Other contracts [Member] | |||
Derivatives and Hedging Activities | |||
Notional amount | 3,436 | 1,258 | |
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | |||
Derivatives and Hedging Activities | |||
Asset | [1] | 2,787 | 3,346 |
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Interest rate contracts [Member] | |||
Derivatives and Hedging Activities | |||
Asset | [1] | 1,107 | 1,735 |
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Equity contracts [Member] | |||
Derivatives and Hedging Activities | |||
Asset | [1] | 1,620 | 1,523 |
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Credit contracts [Member] | |||
Derivatives and Hedging Activities | |||
Asset | [1] | 1 | 1 |
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Foreign exchange contracts [Member] | |||
Derivatives and Hedging Activities | |||
Asset | [1] | 59 | 80 |
Other assets [Member] | Derivatives not designated as hedging instruments [Member] | Other contracts [Member] | |||
Derivatives and Hedging Activities | |||
Asset | [1] | 7 | |
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2] | 2,710 | 3,001 |
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | Interest rate contracts [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2] | 462 | 965 |
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | Equity contracts [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2] | 2,206 | 1,988 |
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | Foreign exchange contracts [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2] | 38 | 47 |
Other liabilities [Member] | Derivatives not designated as hedging instruments [Member] | Other contracts [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2] | 4 | 1 |
Policyholder Account Balances, Future Policy Benefits and Claims [Member] | GMWB and GMAB embedded derivatives [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2],[3] | 188 | 614 |
Policyholder Account Balances, Future Policy Benefits and Claims [Member] | IUL embedded derivatives [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2] | 493 | 464 |
Policyholder Account Balances, Future Policy Benefits and Claims [Member] | EIA embedded derivatives [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2] | 4 | 5 |
Policyholder Account Balances, Future Policy Benefits and Claims [Member] | Total embedded derivatives [Member] | |||
Derivatives and Hedging Activities | |||
Liability | [2] | $ 685 | $ 1,083 |
[1] | The fair value of freestanding derivative assets is included in Other assets on the Consolidated Balance Sheets. | ||
[2] | The fair value of freestanding derivative liabilities is included in Other liabilities on the Consolidated Balance Sheets. The fair value of GMWB and GMAB, IUL, and EIA embedded derivatives is included in Policyholder account balances, future policy benefits and claims on the Consolidated Balance Sheets. | ||
[3] | The fair value of the GMWB and GMAB embedded derivatives as of March 31, 2017 included $585 million of individual contracts in a liability position and $397 million of individual contracts in an asset position. The fair value of the GMWB and GMAB embedded derivatives as of December 31, 2016 included $880 million of individual contracts in a liability position and $266 million of individual contracts in an asset position. |
Derivatives and Hedging Activ61
Derivatives and Hedging Activities (Income Statement) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
Interest credited to fixed accounts [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | $ 12 | $ 11 |
Interest credited to fixed accounts [Member] | IUL embedded derivatives [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (7) | 14 |
Benefits, claims, losses and settlement expenses [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (119) | (25) |
Benefits, claims, losses and settlement expenses [Member] | GMWB and GMAB embedded derivatives [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | 426 | (664) |
Derivatives not designated as hedging instruments [Member] | Interest credited to fixed accounts [Member] | Equity contracts [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | 19 | (3) |
Derivatives not designated as hedging instruments [Member] | Benefits, claims, losses and settlement expenses [Member] | Interest rate contracts [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (75) | 755 |
Derivatives not designated as hedging instruments [Member] | Benefits, claims, losses and settlement expenses [Member] | Equity contracts [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (416) | (65) |
Derivatives not designated as hedging instruments [Member] | Benefits, claims, losses and settlement expenses [Member] | Credit contracts [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (8) | (16) |
Derivatives not designated as hedging instruments [Member] | Benefits, claims, losses and settlement expenses [Member] | Foreign exchange contracts [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | (24) | $ (35) |
Derivatives not designated as hedging instruments [Member] | Benefits, claims, losses and settlement expenses [Member] | Other contracts [Member] | ||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ||
Amount of gain (loss) on derivatives recognized in income | $ (22) |
Derivatives and Hedging Activ62
Derivatives and Hedging Activities (Option Pay/Rec) (Details) $ in Millions | Mar. 31, 2017USD ($) | |
Summary of option premiums payable and receivable | ||
Premiums payable | $ 1,598 | |
Premiums receivable | 755 | |
2017 [Member] | ||
Summary of option premiums payable and receivable | ||
Premiums payable | 210 | [1] |
Premiums receivable | 68 | [1] |
2018 [Member] | ||
Summary of option premiums payable and receivable | ||
Premiums payable | 210 | |
Premiums receivable | 129 | |
2019 [Member] | ||
Summary of option premiums payable and receivable | ||
Premiums payable | 255 | |
Premiums receivable | 171 | |
2020 [Member] | ||
Summary of option premiums payable and receivable | ||
Premiums payable | 176 | |
Premiums receivable | 98 | |
2021 [Member] | ||
Summary of option premiums payable and receivable | ||
Premiums payable | 167 | |
Premiums receivable | 107 | |
2022-2026 [Member] | ||
Summary of option premiums payable and receivable | ||
Premiums payable | 580 | |
Premiums receivable | $ 182 | |
[1] | 2017 amounts represent the amounts payable and receivable for the period from April 1, 2017 to December 31, 2017. |
Derivatives and Hedging Activ63
Derivatives and Hedging Activities (Cash Flow Hedges and Credit Risk) (Details) - USD ($) $ in Millions | 3 Months Ended | |
Mar. 31, 2017 | Dec. 31, 2016 | |
General Cash Flow Hedge Information [Abstract] | ||
Derivatives designated as cash flow hedges | $ 0 | |
Cash flow hedge loss to be reclassified within twelve months | $ 4 | |
Longest period of time over which the entity hedges exposure to the variability in future cash flows | 2 years | |
Derivatives liabilities, credit risk related contingent features | ||
Aggregate fair value of derivative contracts in a net liability position containing such credit contingent instruments | $ 305 | $ 206 |
Aggregate fair value of assets posted as collateral for such instruments | 284 | 198 |
Aggregate fair value of additional assets required to be posted or needed to settle the instruments | $ 21 | $ 8 |
Comprehensive Income (Loss) (De
Comprehensive Income (Loss) (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | ||
Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent [Abstract] | |||
Net unrealized securities gains arising during the period, tax | [1] | $ (13) | $ (165) |
Reclassification of net securities gains included in net income, tax | [2] | 6 | |
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables, tax | 9 | 69 | |
Net unrealized securities gains (losses), tax | 2 | (96) | |
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax, Portion Attributable to Parent [Abstract] | |||
Reclassification of net derivative losses included in net income, tax | [3] | (1) | 0 |
Net unrealized derivatives gains, tax | (1) | 0 | |
Other, tax | 0 | ||
Other comprehensive income (loss), tax | 1 | (96) | |
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax, Portion Attributable to Parent [Abstract] | |||
Net unrealized securities gains arising during the period, pretax | [1] | 38 | 469 |
Reclassification of net securities gains included in net income, pretax | [2] | (17) | |
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables, pretax | (26) | (197) | |
Net unrealized securities gains (losses), pretax | (5) | 272 | |
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax, Portion Attributable to Parent [Abstract] | |||
Reclassification of net derivative losses included in net income, pretax | [3] | 2 | 1 |
Net unrealized derivative gains, pretax | 2 | 1 | |
Other, pretax | (1) | ||
Other comprehensive income (loss), pretax | (4) | 273 | |
Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract] | |||
Net unrealized securities gains arising during the period, net of tax | [1] | 25 | 304 |
Reclassification of net securities gains included in net income, net of tax | [2] | (11) | |
Impact of deferred acquisition costs, deferred sales inducement costs, unearned revenue, benefit reserves and reinsurance recoverables, net of tax | (17) | (128) | |
Net unrealized securities gains (losses), net of tax | (3) | 176 | |
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax, Portion Attributable to Parent [Abstract] | |||
Reclassification of net derivative losses included in net income, net of tax | [3] | 1 | 1 |
Net unrealized derivatives gains, net of tax | 1 | 1 | |
Other, net of tax | (1) | 0 | |
Total other comprehensive income (loss), net of tax | $ (3) | $ 177 | |
[1] | Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income during the period. | ||
[2] | Reclassification amounts are recorded in net realized investment gains. | ||
[3] | Reclassification amounts are recorded in net investment income. |
Shareholder's Equity Shareholde
Shareholder's Equity Shareholder's Equity (Reclassifications) (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | ||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Beginning balance | $ 457 | $ 395 | |
OCI before reclassifications | 7 | 177 | |
Amounts reclassified from AOCI | (10) | 0 | |
Total OCI | (3) | 177 | |
Ending balance | 454 | 572 | |
Net unrealized securities gains [Member] | |||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Beginning balance | 461 | 403 | |
OCI before reclassifications | 8 | 176 | |
Amounts reclassified from AOCI | (11) | 0 | |
Total OCI | (3) | 176 | |
Ending balance | [1] | 458 | 579 |
Noncredit related impairments on securities and net unrealized securities gains (losses) on previously impaired securities | 1 | (2) | |
Net unrealized derivatives gains [Member] | |||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Beginning balance | (4) | (8) | |
OCI before reclassifications | 0 | 1 | |
Amounts reclassified from AOCI | 1 | 0 | |
Total OCI | 1 | 1 | |
Ending balance | (3) | $ (7) | |
Other [Member] | |||
AOCI Attributable to Parent, Net of Tax [Roll Forward] | |||
Beginning balance | 0 | ||
OCI before reclassifications | (1) | ||
Total OCI | (1) | ||
Ending balance | $ (1) | ||
[1] | Includes $1 million and $(2) million of noncredit related impairments on securities and net unrealized securities gains (losses) on previously impaired securities as of March 31, 2017 and March 31, 2016, respectively. |
Income Taxes (Details)
Income Taxes (Details) - USD ($) $ in Millions | 3 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Dec. 31, 2016 | |
Operating Loss Carryforwards [Line Items] | |||
Effective tax rate (as a percent) | 6.70% | 16.40% | |
Quantifying Misstatement in Current Year Financial Statements, Amount | $ (20) | ||
Valuation allowance | 8 | $ 8 | |
Gross unrecognized tax benefits | 67 | 59 | |
Unrecognized tax benefits, net of federal tax benefits that would affect the effective tax rate if recognized | 6 | 6 | |
Net increase (decrease) in interest and penalties | 1 | ||
Payable related to accrued interest and penalties | 3 | $ 2 | |
State and local jurisdiction [Member] | |||
Operating Loss Carryforwards [Line Items] | |||
State net operating losses | $ 8 |
Contingencies (Details)
Contingencies (Details) - Future guaranty fund assessments [Member] - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended |
Mar. 31, 2017 | Dec. 31, 2016 | |
Contingencies | ||
Liability related to guaranty fund assessments | $ 16 | $ 16 |
Related premium tax asset | $ 14 | $ 14 |